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ABSTRACT 
 
Nikolas M. Stasulli: Identification of Host and Bacterial Factors that Contribute to 
Lung Lesion Structure During Pneumonic Plague  
(Under the direction of William E. Goldman) 
 
Yersinia pestis, the causative agent of plague, is a high-priority pathogen that 
continues to cause outbreaks worldwide. The ability of Y. pestis to be transmitted via 
respiratory droplets and its history of weaponization has led to its classification as a 
Tier 1 Select Agent most likely to be used as a biological weapon. The most deadly 
form of disease caused by Y. pestis, pneumonic plague, results from the deposition 
of bacteria into the lungs and has mortality rates approaching 100% in the absence 
of treatment within 24 hours of the onset of symptoms. The Goldman lab has 
previously characterized pneumonic plague progression as biphasic, presenting with 
two distinct disease phases. Rapid bacterial growth during an initial pre-inflammatory 
phase transitions into the second pro-inflammatory phase where disease symptoms 
present and lead to death of the host. Using in vivo analyses and focusing on 
relevant cell types during pneumonic plague infection host pathways can be 
identified that may be manipulated to extend the 24 hour window for treatment of 
pneumonic plague. 
 During pneumonic plague, the bacterium Yersinia pestis elicits the 
development of neutrophil-rich inflammatory lung lesions that continue to expand, 
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eventually consolidating entire lobes of the lung during infection. This lesion 
development and persistence is poorly understood. In this dissertation I examine 
spatially distinct regions of lung lesions using laser capture microdissection and 
RNAseq to identify transcriptional differences between lesion microenvironments. I 
provide evidence that cellular pathways involved in leukocyte migration and 
apoptosis are down-regulated in the center of lung lesions compared to the 
periphery. Probing for the bacterial factor(s) important for the alteration in neutrophil 
survival, I provide evidence that Y. pestis increases neutrophil survival through a 
mechanism that is dependent on the type III secretion system effector YopM. 
Additionally, I investigate the roles of reactive oxygen and nitrogen species that are 
typically used as neutrophil defense mechanisms, and provide evidence that these 
molecules are important for controlling early establishment of Y. pestis in the lungs. 
This research explores the complexity of spatially distinct host-microbe interactions 
in vivo and emphasizes the importance of cell-relevant assays in understanding Y. 
pestis virulence.  
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CHAPTER 1: INTRODUCTION 
 
1.1 Overview 
The causative agent of the disease known as “plague” was identified 
independently in August of 1894 by both Alexandre Yersin and Shibasaburo 
Kitasato. Yersin, however, is primarily credited with the official identification because 
of his more accurate and descriptive paper describing the gram-negative 
coccobacillus, which he named Bacterium pestis. He continued his research and by 
1900 had used antiserum to cure a plague patient, and ultimately made the link 
between rats and plague outbreaks (Hirst, 1953; Zietz and Dunkelberg, 2004). The 
name of the bacterium identified by Yersin has changed several times since its 
discovery: first in 1900 to Bacillus pestis, then in 1923 to Pasteurella pestis (after 
Louis Pasteur, Yersin’s mentor), then finally in 1970 to Yersinia pestis (after its 
identifier) (Zietz and Dunkelberg, 2004).  
Y. pestis is a high-priority pathogen that poses a severe threat to both human 
and animal health, and continues to cause modern day plague outbreaks worldwide 
(Inglesby et al., 2000; Stenseth et al., 2008). The ability of Y. pestis to be transmitted 
via respiratory droplets and its past weaponization has led to its classification as a 
Tier-1 select agent that must be handled under strict biosafety level 3 (BSL3) 
conditions. The natural re-emergence of plague as a global public health threat is 
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also of concern since the identification of the first antibiotic resistant strains of Y. 
pestis in 1995 (Galimand et al., 2006). 
The most deadly form of plague disease known as primary pneumonic plague 
results from the inhalation of Y. pestis. The Goldman lab has previously 
characterized pneumonic plague in a murine model as a biphasic disease with an 
initial anti-inflammatory phase followed by rapid activation of the innate immune 
system (Lathem et al., 2005). If antibiotic treatment is not administered within 24 
hours after the onset of symptoms, the disease approaches 100% mortality 
(Inglesby et al., 2000). While not the most common form of plague disease, 
pneumonic plague is of the highest concern when considering transmission and 
disease treatment. The rapid bacterial growth in the lung during the initial anti-
inflammatory phase primes the patient to be infectious to others once disease 
symptoms emerge. Additionally, the rapid disease progression can lead to death 
before Y. pestis infection can be diagnosed and confirmed. 
 
1.2 Manifestations of plague 
 The identification of small mammals as the reservoir of endemic plague 
infections was established in 1927. The natural transmission cycle of Y. pestis 
between small mammals and fleas was termed sylvatic plague (Zietz and 
Dunkelberg, 2004). As humans unintentionally enter this sylvatic cycle (or as Y. 
pestis is intentionally dispersed through nefarious means) there are three 
manifestations of disease that can result: bubonic, pneumonic, and septicemic 
plague. 
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1.2.1 Bubonic plague 
Bubonic plague is the most common disease caused by Y. pestis. Bubonic 
plague can be caused by contamination of open wounds or direct inoculation 
through the bite of an infected flea (Riedel, 2005). After establishing in the dermis, Y. 
pestis infiltrates the cutaneous lymphatics and migrates to the nearest draining 
lymph node (Gonzalez et al., 2015; Riedel, 2005). After an incubation period of 2-6 
days after inoculation, there is a sudden onset of flu-like symptoms followed by a 
swelling of the draining lymph nodes that forms the namesake “buboes” (Riedel, 
2005). In the pre-antibiotic era the mortality rate of bubonic plague could reach as 
high as 70% during epidemics (Stenseth et al., 2008). Today, with early detection 
and treatment, mortality has dropped to as low as 5% (Inglesby et al., 2000). Even if 
a patient recovers form bubonic plague, buboes may remain for several weeks after 
symptoms have dissipated (Riedel, 2005).  
 
1.2.2 Pneumonic plague 
When Y. pestis colonizes the lower respiratory system either secondary or 
primary pneumonic plague will result. Secondary pneumonic plague occurs after 
bubonic or septicemic plague disseminates into the lung compartment, allowing it to 
be spread by aerosol from person-to-person. Primary pneumonic plague occurs after 
inhalation of Y. pestis directly into the lungs. This can occur by person-to-person 
transmission, through aerosolizing bacteria (i.e. butchering an infected animal), or 
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during the intentional release of an aerosol as a biological weapon (Inglesby et al., 
2000). It is believed that person-to-person transmission via respiratory droplets 
occurs within approximately one meter of an infected individual (Kool, 2005). Further 
discussion of pneumonic plague epidemiology throughout modern times can be 
found in Section 1.3.3 of Chapter 1. 
There is a short quiescent time of 1-3 days after inhalation of bacteria before 
flu-like symptoms emerge. Unfortunately, pneumonic plague must be treated within 
24 hours after symptoms begin or mortality approaches 100% only three to four days 
after inhalation (Inglesby et al., 2000). Disease progression and symptoms are 
similar in the murine model of infection. Based on our animal model, the progression 
of pneumonic plague is biphasic: an initial anti-inflammatory phase precedes a pro-
inflammatory phase of disease. In the first phase, bacteria are present in the lungs 
and freely replicate with little to no detectable immune responses. Disease 
symptoms, increased cytokine levels, and the infiltration of neutrophils into the 
airways signal entry into the pro-inflammatory phase of infection. Pneumonic plague 
can be characterized by the formation of lung lesions followed by destruction of 
surrounding alveolar architecture. Condensed pockets of Y. pestis surrounded by 
innate immune cells, primarily neutrophils, form these pulmonary lesions (Lathem et 
al., 2005). Death from pneumonic plague can be attributed to pneumonia due to 
alveolar destruction and the subsequent septicemia late in disease resulting from 
dissemination of bacteria from the lungs (Finegold et al., 1968).  
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1.2.3 Septicemic plague 
If Y. pestis manages to infiltrate the bloodstream of the host the disease will 
manifest as septicemic plague. Primary septicemic plague from direct inoculation of 
Y. pestis into the blood stream is fairly rare. However, secondary septicemic plague 
often results during the late stages of bubonic and pneumonic plague. Once bacteria 
have disseminated from initially localized sites, septicemia can induce shock, blood 
clots leading to gangrenous extremities, multiple organ failure, and respiratory 
distress (Riedel, 2005).  
 
1.3 History and epidemiology of plague 
The disease caused by Yersinia pestis known as “plague” has been 
described for thousands of years. It is generally agreed upon by scholars that the 
oldest written mention of plague is recounted in the Bible (1 Samuel 5&6) referring to 
a time between 1320 – 1000 BC (Griffin, 2000; Ligon, 2006). This bacterium has 
also been responsible for 3 major pandemics throughout recorded history that were 
so devastating to the population that it completely altered the makeup of society. 
 
1.3.1 The Justinian pandemic 
The first major plague pandemic is now referred to as the “plague of 
Justinian”, after the presiding emperor of Rome. The pandemic may have started as 
early as 532 BC, but definitively took hold in 541/42 BC with outbreaks in 
Constantinople and Greece (Ligon, 2006; Zietz and Dunkelberg, 2004). It is believed 
	   6	  
that ~40% of Constantinople’s population died during this outbreak. After disease 
spread through trade routes, up to 100 million Europeans are believed to have 
succumbed to plague over the next 250 – 300 years as pockets of disease 
continually reemerged. This devastating death toll depleted trade occupations, the 
ability to form armies, and the ability to staff many of the religious monasteries 
throughout Europe and Western Asia (Ligon, 2006). 
 
1.3.2 The Black Death   
The second and most well known plague pandemic is commonly referred to as “The 
Black Death”. The initial outbreak is thought to have started in China in the 1330’s. 
The disease then spread west through trade routes and began establishing itself in 
Europe. From 1346 – 1352 the spread of Y. pestis resulted in the death of over 25 
million people, over one-third of the world’s population at the time. Another 20 million 
were believed to have died by the end of the century. This pandemic lasted through 
the 1720’s, decimating large cities with resurgences throughout Europe (Ligon, 
2006; Zietz and Dunkelberg, 2004).  
 With over one-third of the world’s population deceased within 6 years, this 
pandemic had wide rippling effects throughout society. Commerce, trade, and 
government came to a near standstill, and the economy of Europe collapsed from 
the large and sudden loss of life. The population and economy only began to 
rebound in the late 1600’s. Interestingly, in Western Europe, the sudden decrease in 
the peasant population caused increased competition for the remaining, now 
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valuable, laborers. This competition is believed to have started an early form of 
capitalism and led to the rise of a “middle class” that was not present prior to the 
pandemic. Culture throughout Europe also began to morph and took on a macabre 
tone, with the influence of death permeating artwork, literature, and music. Many 
people at the time became more religious, as evidenced by the canonization of new 
“plague saints” by the Catholic Church. Unfortunately, this new-found focus on 
religion also caused societal rifts as Christians, Muslims, and Jews all blamed each 
other for incurring “God’s wrath” and causing the horrible disease (Ligon, 2006; Zietz 
and Dunkelberg, 2004). 
 
1.3.3 The Modern pandemic: global spread, and tracking of pneumonic plague 
The “modern pandemic” of plague is believe to have started in China around 
1855 in the Yunnan province, and marked a critical point in the dissemination of 
plague into a global issue. By 1894 plague had reached Hong Kong and, with the 
growth of the trans-oceanic shipping industry, lead to global spread of Y. pestis 
(Caten and Kartman, 1968; Ligon, 2006; Zietz and Dunkelberg, 2004). Stowaway 
rats on shipping vessels would transport Y. pestis, and the flea vectors that transmit 
it, across oceans. The first reported incidence of plague in the Western Hemisphere 
came in Santos, Brazil in October of 1899 (Furman and Williams, 1973), and marked 
the beginning of three decades of large epidemics throughout the world. Between 
1900-1930 every continent except Antarctica experienced outbreaks of plague 
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(Ligon, 2006). Even Australia, which has not had a case of plague since 1925, was 
struck with over 1,300 cases of plague in the first part of the 1900’s (Garrett, 1991).  
In the United States, this first quarter of the 20th century also saw several 
epidemics of plague in California. The first epidemic occurred from 1900-1904 in a 
Chinese immigrant-populated district of San Francisco. This was followed by a 
second outbreak in San Francisco in 1907. These two outbreaks included both 
bubonic and pneumonic plague cases, infecting over 280 people. A smaller epidemic 
occurred in 1919 in Oakland, CA, where a man developed secondary pneumonic 
plague and became the source of 13 primary pneumonic plague cases, 12 of whom 
died (Anderson, 1978; Caten and Kartman, 1968; Kool, 2005). This was also 
documented as the first instance of a primary pneumonic plague epidemic in the 
Western Hemisphere (Kellogg, 1920). The fourth US outbreak occurred in Los 
Angeles in late 1924, and was also caused by pneumonic plague, resulting in 39 
documented cases with 33 deaths (Anderson, 1978; Kool, 2005). A fifth outbreak 
occurred around the Gulf Coast of the United States in 1924, causing over 70 cases 
of plague (Anderson, 1978).  
 While there was a spike of plague cases in the United States between 1900-
1908 and again between 1918-1926, after the mid-1920’s there were relatively few 
yearly cases of plague. However, unlike Australia that was seemingly able to 
eradicate plague disease after 1925 (Garrett, 1991), endemic sylvatic plague 
established itself in small-mammal populations in the U.S. west of the Mississippi 
River (Anderson, 1978; Caten and Kartman, 1968). According to compiled 
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information from the Centers for Disease Control and Prevention and other 
published sources, beginning in the mid-1960’s through the 1970’s and into the early 
1980’s, there was a resurgence of plague cases in the U.S. (Anderson, 1978). These 
cases were located throughout the Southwestern U.S., mainly New Mexico, Arizona, 
and California (Anderson, 1978; Kaufmann et al., 1980). Between 1900 and 2010, 
there were over 1,400 reported cases of plague in the contiguous U.S. and Hawaii 
(Kaufmann et al., 1980). Of these U.S. cases, as many as 20% have been due to 
pneumonic plague.  
 In addition to the two pneumonic plague outbreaks in California in the early 
1900’s, there have been several global instances of pneumonic plague outbreaks 
during the “modern plague” era. The largest of these epidemics took place in the 
Manchuria region in China. This region had large pneumonic plague epidemics in 
1910-1911 and again in 1920-1921 that left ~60,000 and ~9,300 people dead, 
respectively (Wu et al., 1936). Interestingly, the larger of the two epidemics in 1910-
1911 was caused by a dramatic increase in the price of marmot fur. Thousands of 
poor laborers flocked to this region of China to hunt marmots, whose population was 
unknowingly endemically infected with Y. pestis. The butchering and eating of these 
animals by hunters unwittingly aerosolized the bacteria and caused a major 
epidemic (Summers, 2012). China continues to have relatively large numbers of 
plague cases yearly. Between 1994-2003 there were 11 countries that reported 
more than 100 confirmed cases of plague (China being number 11). The country 
with the highest rate of plague during this time was Madagascar, with approximately 
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3% of cases being pneumonic plague. For this 10 year time period, that equates to 
over 350 cases of pneumonic plague (Butler, 2009). In the first full decade of the 21st 
century, however, the WHO reported that the Congo became the number one 
reporting country with over 10,500 cases of plague. This increase in cases also 
coincided with a large pneumonic plague outbreak in 2005-2006 in the Oriental 
Province that left over 130 people dead from pneumonic plague alone (Butler, 2013). 
There should continue to be a heightened awareness of outbreaks of pneumonic 
plague to ensure that larger epidemics do not continue to occur, especially with the 
identification of naturally antibiotic-resistant Y. pestis strains (Galimand et al., 2006).  
 
1.4 Yersinia pestis as a biological weapon 
The first known use of Y. pestis as a biological weapon dates back to 1346 
during the war between the Tartar army and Genoese sailors at the port city of 
Caffa. The Tartars were losing many of their soldiers to plague, and out of 
desperation placed the corpses of people who had died of plague onto catapults and 
flung them over the city walls to infect enemy troops. Similar corpse-catapulting 
strategies were documented in 1422 by the Lithuanians and in 1710 by the Russians 
(Ligon, 2006; Riedel, 2004).  
During World War II, the Japanese army established a research program 
(Unit 731) that secretly studied biological-warfare agents. This unit extensively 
studied Yersinia pestis, and infected fleas were released over the Chinese 
population several times in the early 1940’s. “Bombs” were built and tested that were 
constructed of clay pots filled with Y. pestis carrying fleas encased in rice and paper. 
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It is believed that tens-of-thousands of people died from plague epidemics 
throughout China during the 1940’s due to Unit 731’s biological-weapon 
experiments. Unit 731’s field tests of Y. pestis on the Chinese people were ceased 
after Japanese troops died of plague due to the unpredictability of the fleas and 
spread of disease (Ligon, 2006; Riedel, 2004; Williams and Wallace, 1989). 
After WWII, biological weapons programs were slowly dismantled, starting 
with the United Kingdom shutting down its program in 1950. The United States 
followed suit in 1969, but only after developing at least seven type-classified 
microorganisms into biological weapons. The shut down of the US biological 
weapons program preceded the drafting of the Biological and Toxin Weapons 
Convention (BWC) in 1972. The BWC called for multilateral disarmament of all 
biological weapons. The Soviet Union, however, continued with their biological 
weapons program until 1992 despite signing the BWC (Ligon, 2006; Riedel, 2004).  
In 1970 just prior to the drafting of the BWC, the WHO convened a group of 
experts to determine the casualties that would be expected from an aerosolized 
biological attack from several select agents. The WHO committee determined that, 
under their defined parameters, the release of 50 kg of aerosolized Y. pestis over an 
economically developed city of 5,000,000 people would result in the incapacitation of 
150,000 and death of 36,000 people, assuming prompt action is taken following the 
attack. Out of all biological weapon agents surveyed by this committee, only B. 
anthracis would cause more casualties, most likely due to its ability to travel farther 
and stay viable for much longer than Y. pestis. Unlike Anthrax, however, Y. pestis 
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can be spread from person to person, and any extended delay in initiating treatment 
could cause casualty numbers to rise. A sylvatic reservoir of Y. pestis could also be 
established if small mammals become infected during an attack. Along with the 
presence of susceptible flea populations, this new rodent reservoir could lead to 
more long-term effects of recurring bubonic plague due to the establishment of a 
sylvatic cycle. This assessment of biological and chemical weapons has been 
updated as recently as 2004 (World Health Organization, 2004). Despite the unlikely 
use of Y. pestis as a biological weapon there has also been an assessment of 
antibiotic treatment courses recommended in the case of both contained or mass 
casualty outbreaks (Inglesby et al., 2000). 
Modeling of well-documented pneumonic plague outbreaks in the 20th century 
has found that R0=~1.3 (the ability of an infection to sustain itself in a population). An 
R0<1 indicates that an infection cannot sustain it self in a population. An R0>1 
indicates that pneumonic plague has the potential to sustain itself and spread in a 
population if action is not taken to control the infection. However, an R0 value so 
close to 1 signifies the need for close proximity to infect and a small window of 
transmission before symptoms begin. The disease could be stopped through 
isolation of infected individuals and antibiotic treatment for those who have come into 
contact with the infected (Gani and Leach, 2004). 
 
1.5 Pulmonary immune defense and neutrophils  
The respiratory tract is continuously in contact with a diverse repertoire of 
constantly changing environmental antigens. To continue functioning efficiently, the 
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lungs must maintain an immunological homeostasis, balancing between potentially 
harmful and non-harmful antigens. Recognition of antigens begins in the mucosal 
tissue of the conducting airways. The airway epithelial cells (AECs) are the first line 
of defense. The AECs act as a physical barrier, but also secret proteins and 
peptides into the lung mucosa to defend against invading pathogens (Holt et al., 
2008). Secreted proteins and molecules such as lysozyme, peroxidase, lactoferrin, 
defensins, collections, ficolins, and complement factors can all directly act on 
invading microbes to promote killing and help ensure lung homeostasis (Tsai and 
Grayson, 2008). From the conducting airways, the bronchi of the lungs continue to 
branch and form the parenchymal lung, consisting of bronchioles and alveolar ducts, 
and terminates in alveolar sacs that are necessary for oxygen exchange (Holt et al., 
2008). Besides the AECs there are various resident dendritic cells and macrophages 
that patrol and sample the mucosa and alveolar spaces to ensure proper 
homeostasis and recruit additional immune cells if necessary (Guilliams et al., 2013; 
Holt et al., 2008).  
In addition to the resident immune cells, neutrophils are an important and 
necessary component of the innate immune system. Neutrophils are short-lived cells 
that are constantly being generated in the bone marrow, circulating in the blood 
stream, and then returning to the bone marrow for cellular turnover. During their 
circulation, neutrophils also monitor the lung environment for invading pathogens. 
During a bacterial infection neutrophils are rapidly called to the site of insult and can 
quickly activate a myriad of antimicrobial functions in an attempt to control invading 
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pathogens (Craig et al., 2009; Segal, 2005). This rapid antimicrobial response is 
facilitated by neutrophil priming that results from signals initiated by the innate 
immune system upon detection of a pathogen. This priming retains neutrophils in the 
lungs as they “survey” during normal circulation (Singh et al., 2012; Summers et al., 
2010). Upon direct interaction with a secondary stimulus, such as invading microbes, 
there is enhancement of the respiratory burst, cytoskeletal rearrangements that 
retain neutrophils in the lung and facilitate phagocytosis, regulation of neutrophil 
surface antigens (Singh et al., 2012), and release of antimicrobial peptides/proteins 
from granules (Kobayashi et al., 2003). After mounting an antimicrobial response, 
neutrophils ordinarily undergo necrosis, apoptosis, or NETosis, all of which ultimately 
lead to macrophage infiltration. The newly infiltrated macrophages facilitate the 
clearance of dead or dying neutrophils as well as any remaining bacteria (Brinkmann 
et al., 2004; Kebir and Filep, 2013; Luo and Loison, 2008; Silva, 2011). This double 
priming, however, can lead to acute lung injury if the neutrophils are not efficiently 
released from the pulmonary compartment back into circulation, or appropriate 
neutrophil turnover and removal does not occur (Singh et al., 2012; Summers et al., 
2010). There is also data to suggest that there is cross talk between neutrophils and 
various other cell types at sites of inflammation that can promote a continued innate 
immune response and even bridge the gap between innate and adaptive immunity 
(Mantovani et al., 2011). 
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1.6 Pathogenesis and innate immune response during pneumonic plague 
Pathogenic microbes have evolved ways to evade the immune system of the 
hosts that they infect. The work presented in this dissertation is focused on the 
ability of bacteria to manipulate activated neutrophils (Urban et al., 2006), resulting in 
increased disease severity and mortality (Balamayooran et al., 2010). Pathogens 
have been shown to utilize various mechanisms to alter neutrophil function including 
inhibiting neutrophil chemotaxis (Bignold et al., 1991; de Haas et al., 2004; Van Dyke 
et al., 1982), preventing phagocytosis (Grosdent et al., 2002; Spinner et al., 2013; 
2008; Visser et al., 1995), altering degranulation (Arnett et al., 2014; Bertram et al., 
1986), and, importantly for this work, inhibiting neutrophil apoptosis (Choi et al., 
2005; Erttmann et al., 2014; Ge and Rikihisa, 2006; Schwartz et al., 2013; 2012). 
Despite the recruitment of neutrophils to control Y. pestis in the lungs, 
bacterial numbers continue to increase throughout the duration of infection (Lathem 
et al., 2005). The increase in bacterial burden coincides with continued neutrophil 
recruitment, accumulation in the lungs, and subsequent targeting of neutrophils by 
the Y. pestis type III secretion system (T3SS) (Marketon et al., 2005; Pechous et al., 
2013). The massive neutrophilic infiltration during pneumonic plague results in the 
formation of histopathologically distinct lung lesions that arise during the later (pro-
inflammatory) phase of disease. These lesions expand in the lungs as neutrophils 
continue to accumulate until death of the host, with no evidence of bacterial or 
neutrophil clearance (Lathem et al., 2005). The continued influx of neutrophils and 
their apparent prolonged survival is contrary to typical neutrophil function but has 
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also been observed in neutrophils of cystic fibrosis patients (Tirouvanziam et al., 
2008). The continuous neutrophil influx during pneumonic plague results in alveolar 
destruction within lung lesions and culminates in a severe and deadly necrotizing 
pneumonia (Finegold et al., 1968).  
Yersinia pestis is known to inhibit the host immune response via various 
virulence mechanisms (Ben-Gurion and Shafferman, 1981; Du et al., 2002; Jackson 
and Burrows, 1956; Lathem et al., 2007; Trosky et al., 2008). However, It has just 
recently been appreciated that the functions of specific T3SS effectors may vary 
depending on the cell type being targeted (Spinner et al., 2010). Neutrophils are the 
most prominent immune infiltrate during pneumonic plague, are selectively targeted 
by Y. pestis, and are necessary for development of lung lesions (Pechous et al., 
2013). Early recruitment of neutrophils is also linked to decreased bacterial burden 
and increased survival of Y. pestis infected mice (Vagima et al., 2015).  
In the Yersinia pestis field, pneumonic plague is fairly understudied as a 
separate disease from bubonic plague despite the dissimilar disease progression. 
Most research is done using bubonic plague models or in in vitro assays. These 
results are usually inferred, but not directly tested, to be relevant during pneumonic 
plague. Relatively few laboratories use fully virulent Y. pestis to specifically study the 
effects of virulence factors on pneumonic plague (Cantwell et al., 2010; Lathem et 
al., 2007; van Lier et al., 2014). Most other groups working on pneumonic plague 
use attenuated strains missing either the pigmentation locus or the pCD1 plasmid 
(Fetherston et al., 2010; Galvan et al., 2010; Lee-Lewis and Anderson, 2009). This 
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dissertation and other studies from the Goldman lab continue to show the necessity 
of using fully virulent Y. pestis and in vivo infections by presenting data that could not 
be elucidated in less pathogenic models (Lathem et al., 2005; Pechous et al., 2013; 
2015; Price, 2011). 
 
1.7 Significance 
Endemic maintenance of Yersinia pestis in sylvatic cycles continues to cause 
spikes of plague disease around the world. Despite the signing of the BWC there is 
still fear of Y. pestis being used as a biological weapon during acts of terrorism. With 
the vague symptoms and rapid progression of pneumonic plague, it remains 
important to be vigilant and continue to characterize this disease, particularly 
focusing on more effective late-stage treatments. With the development of 
pneumonia being caused by the continued replication of Y. pestis and infiltration of 
neutrophils into the pleural cavity, it is important to move away from in vitro studies 
and to study the disease in a more relevant in vivo setting. 
I hypothesized that spatially distinct transcriptional modulation of the 
important neutrophil population would be observable in Y. pestis lung lesions. This 
line of in vivo questioning, which could not be undertaken in vitro, specifically looked 
at the most relevant cell type important during pneumonic plague disease. In this 
body of work, fully virulent Y. pestis is employed along with the novel use of laser 
capture microdissection (LCM) and RNAseq technology to evaluate host 
transcription within the expanding neutrophil-rich lung lesions that arise during 
pneumonic plague. I hoped to identify novel cellular responses that are necessary in 
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vivo for disease progression, and to characterize both bacterial and host factors 
responsible for the distinctive pneumonic plague lung lesions that form late during 
infection. It is necessary to interrogate this inflammatory environment in the context 
of neutrophils to understand how interactions with Y. pestis determine pneumonic 
plague presentation and progression. By determining how interaction of Y. pestis 
and neutrophils induce responses uniquely within sites of infection, the scientific 
community will better understand the mechanisms by which neutrophils typically 
work in a broad range of diseases in which neutrophil infiltration becomes harmful to 
the host. 
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CHAPTER 2: CHARACTERIZATION OF THE LUNG LESION 
MICROENVIRONTMENT BY LASER CAPTURE MICRODISSECTION AND 
RNAseq ANALYSIS*  
 
2.1 Overview 
This chapter describes the use of fully virulent Y. pestis, laser capture 
microdissection (LCM), and RNAseq technology to evaluate host transcription within 
the expanding neutrophil-rich lung lesions that arise during the pro-inflammatory 
disease phase of pneumonic plague. This work provides evidence that lung lesions 
begin as small foci that expand outward throughout infection, and that Y. pestis 
inhibits apoptosis of neutrophils in the center of lung lesions compared with those 
found around the lesion periphery. This work is the first application of LCM to 
evaluate the effects of a bacterial pathogen on a microenvironment within its host 
during infection. This novel use of LCM allowed us to identify spatially distinct 
transcriptional changes in vivo within sites of tissue injury that cannot be 
characterized in vitro. This work evaluates how interactions with Y. pestis induce 
unique transcriptional responses in neutrophils within spatially distinct sites of  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
* This data has been published in: Stasulli NM, Eichelberger KR, Price PA, Pechous 
RD, Montgomery SA, Parker JS, Goldman WE. 2015. Spatially distinct neutrophil 
responses within the inflammatory lesions of pneumonic plague. mBio 6(5):e01530-
15. doi:10.1128/mBio.01530-15. 
	   26	  
infection. Research of this nature will better help expound on mechanisms by which 
neutrophils typically work in a broad range of diseases where neutrophil infiltration 
becomes harmful to the host.  
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2.2 Introduction 
Large dataset analyses have become invaluable for new and innovative 
research in the bacterial pathogenesis field. Several studies have investigated the 
regulation of the Yersinia transcriptome by both microarrays (Du et al., 2009; Han et 
al., 2007; Liu et al., 2009; Pechous et al., 2015; Sebbane et al., 2006; Zhou et al., 
2006) and deep sequencing (Koo et al., 2011; Schiano et al., 2014; Yan et al., 2013) 
under varying environmental conditions in vitro and during disease in vivo. Very few 
studies, on the other hand, have focused on the transcriptional changes of the host 
during Y. pestis infection. One microarray study by Liu et al. evaluated both bacterial 
and host transcription in multiple organs by qRT-PCR and microarray analysis after 
pulmonary challenge with Y. pestis. This host analysis focused on transcriptional 
changes in cytokines (Liu et al., 2009). A less high-throughput study using Northern 
blot analysis also observed transcriptional changes in human neutrophils after 
interaction with Y. pestis (Subrahmanyam et al.).         
Despite previous research on interactions between neutrophils and Y. pestis 
in vivo (Laws et al., 2010; Lukaszewski et al., 2005; Marketon et al., 2005; Pechous 
et al., 2013; Shannon et al., 2013), there is little information to explain the 
architecture and rapid expansion of neutrophil-rich lesions that are the pathological 
hallmark of pneumonic plague. Previous research has indicated that Y. 
pseudotuberculosis regulates its genes spatially within infected tissue (Davis et al., 
2015). Combined with the information that bacterial pathogens can alter neutrophil 
gene expression (Schwartz et al., 2013; Subrahmanyam et al.), the research in this 
chapter investigates the possibility that spatially distinct transcriptional modulation of 
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neutrophils is observable in lung lesions that develop during pneumonic plague.  
Laser capture microdissection (LCM) was first described in 1996 (Emmert-
Buck et al., 1996), and is a technique that can be used to investigate spatial gene 
regulation in tissue samples. The work in this dissertation was performed using a UV 
laser Zeiss P.A.L.M. microscope. With this system, lung tissue slices are adhered 
onto a slide containing a polyethylene napthalate membrane for use with the UV 
laser. The laser is focused and cuts around the desired section of tissue. The 
defocused laser is then pulsed in the center of the cut membrane where it is 
catapulted off of the slide and into an RNA preserving resin in the top of an 
Eppendorf tube, where the RNA can be isolated for downstream applications 
(Espina et al., 2007; Schütze et al., 2007). This technique is sophisticated enough to 
allow for DNA, RNA, and protein extraction at the single-cell level (Suarez-Quian et 
al., 1999). Its use in the field of microbial pathogenesis, however, has rarely been 
exploited and has mainly been limited to plant pathogens (Balestrini et al., 2007; 
Berruti et al., 2013; Klink et al., 2005; Klink and Matthews, 2008; Klink et al., 2007) 
or in vitro studies (Schulte et al., 2011). 
 
2.3 Methods 
All reagents were obtained form Sigma-Aldrich™ unless otherwise noted. 
 
2.3.1 Ethics statement 
The use of live vertebrate animals was performed in accordance with the 
Public Health Service (PHS) policy on Humane Care and Use of Laboratory Animals, 
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the Amended Animal Welfare Act of 1985, and the regulations of the United States 
Department of Agriculture (USDA). All animal studies were approved by the 
University of North Carolina at Chapel Hill Office of Animal Care and Use, protocols 
#12-028.0 and #15-022.0. 
 
2.3.2 Bacterial strains and culture conditions 
The fully virulent Yersinia pestis strain CO92 was obtained from the U.S. 
Army, Ft. Detrick, MD. Y. pestis was grown on brain-heart infusion (BHI) agar (Difco 
Laboratories) at 26°C for two days. For infections, liquid cultures of Y. pestis CO92 
were grown in BHI broth for 6–12 h at 26°C. The cultures were then diluted to an 
OD620 of 0.05–0.1 in BHI supplemented with 2.5 mM CaCl2 and grown 12–16h at 
37°C with constant shaking.  
 
2.3.3 Animals and infections 
Six- to eight-week old female C57BL/6J mice were obtained from Jackson 
Laboratories. Mice were provided with food and water ad libitum and maintained at 
25°C and 15% humidity with alternating 12 h periods of light and dark. For animal 
infections, groups of three to ten mice were lightly anesthetized with 
ketamine/xylazine and inoculated intranasally with a lethal dose of 104
 
colony-
forming units (CFUs) suspended in 20μL PBS. Actual CFUs inoculated was 
determined by plating serial dilutions of the inoculum on BHI.  
 
	   30	  
2.3.4 Tissue preparation, Laser Capture Microdissection, and RNA isolation 
 All solutions are either RNase free or have been treated with 
diethylpyrocarbonate (DEPC). Lungs were inflated via tracheal cannulation with 
RNAlater® (Ambion®) and incubated for 30 min. Lungs were then fully inflated with 
4% fresh paraformaldehyde and incubated for 2 h for fixation and removal from the 
BSL 3 laboratory. Lungs were placed in phosphate buffer (pH 7.4) with 30% Sucrose 
and 20% O.C.T. compound (Tissue-Tek®) for 3 h with intermittent inverting. Lungs 
were removed, covered in O.C.T. for 10 min, frozen on dry ice, and stored at -80°C. 
 Lungs were sectioned into 20-μm slices using a Leica®-1850 cryostat and 
adhered to 1.0 mm PEN-MembraneSlides (Zeiss™). To remove O.C.T. media from 
sections, slides were dipped in 100% ethanol and allowed to dry, incubated in 
DEPC-treated water for 3-5 min, then dipped into increasing concentrations of 
ethanol (70%, 95%, 100%) and allowed to fully dry. 
 For LCM, slides were then loaded onto a Zeiss PALM LCM microscope and a 
4X objective was used to observe lung lesions. Opaque AdhesiveCap Eppendorf 
tubes were loaded and positioned directly over the slides. The desired sections of 
each lung lesion were traced, cut by a laser, and laser pulse-catapulted into the resin 
preservative in the top of the AdhesiveCap tubes. The tubes containing isolated 
lesion pieces were stored at -80°C prior to RNA isolation. Total RNA was isolated 
from the LCM-extracted lesion pieces using an RNeasy FFPE kit (Qiagen™) as per 
the manufacturers instructions with the exception of a 3 h incubation at 56°C after 
the addition of proteinase K.  
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For bone marrow neutrophil isolation, femurs of C57BL/6J mice were 
collected and flushed with cold PBS to extract marrow. Marrow cells were 
disaggregated by repetitive passes through an 18 gauge needle. Bone marrow 
neutrophils (BM-PMNs) were then isolated using a MACS Neutrophil isolation kit 
(Miltenyi Biotec) per the manufacturer’s instructions. The final volume of BM-PMNs 
was resuspended in TRIzol® Reagent (Ambion®) and total RNA was isolated per 
the manufacturer’s instructions.  
 
2.3.5 RNAseq library prep and analysis 
 Total RNA was sent for library preparation and sequencing at the High 
Throughput Sequencing Facility at The University of North Carolina at Chapel Hill. 
Briefly, a Qubit™ RNA Assay Kit for use with a Qubit® Fluorometer was used to 
quantify the total RNA concentration of each sample. Both eukaryotic and 
prokaryotic ribosomal-RNA was then removed from the samples using an 
Epidemiology Ribo-Zero™ Magnetic Gold Kit (Epicentre®). Complementary DNA 
was generated using a SMARTer® Universal Low Input RNA Kit (Clontech®) 
followed by RNAseq library sequencing template preparation using a Low Input 
Library Prep Kit (Clontech®). The library was prepared and run on a MiSeq® 
sequencer (Illumina®) to test the quality of the library. After library verification, 
samples were diluted and barcoded for paired end amplification and clustered 
(TruSeq® SBS Kit v2 (200cycles) and TruSeq® PE Cluster Kit v2 (Illumina®)) using 
a cBot™ (Illumina®) for running on a HiSeq® 2000 system (Illumina®). Quality 
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control steps throughout the RNAseq library preparation were performed using a 
DNA 12K Analysis Kit (Experion®) or a LabChipGX HT DNA LabChip® Kit 
(Caliper™). All MiSeq and HiSeq kits used the v2 chemistry.  
 Purity filtered reads were aligned to the Mus musculus reference genome 
(mm9) using MapSplice (Davis et al., 2015; Wang et al., 2010). The alignment profile 
was summarized by Picard Tools (Broad Institute) v1.64. Aligned reads were sorted 
and indexed using SAMtools (Li et al., 2009; Schwartz et al., 2013; Subrahmanyam 
et al.), translated to transcriptome coordinates, and filtered for indels, large inserts, 
and zero mapping quality using UBU v1.0. Transcript abundance estimates for each 
sample were performed using an Expectation-Maximization algorithm implemented 
in RSEM (Li and Dewey, 2011) based on the UCSC knownGene definitions. Raw 
counts were normalized to the upper quartile (Bullard et al., 2010). Log transformed 
normalized gene expression estimates were assessed for differential expression 
using Student’s t-test, and these results were filtered to highlight genes achieving p < 
0.05 in both comparisons (BM-PMN and lung lesions). Cluster analysis was 
performed to assess the patterns of differential expression (hierarchical clustering 
based on complete linkage and a Pearson correlation) for several defined gene sets 
testing for differential activity between the conditions. The gene set test performed a 
Wilcoxon rank-sum test of the log fold change estimates between genes in a set and 
those in the entire transcriptome where there were greater than three gene 
reads. Gene set results were visualized using density plots in R (version 3.1.1). Raw 
RNAseq data is available on the NCBI repository, series record GSE70819. 
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2.4 Results 
2.4.1 Characterizing host gene regulation in spatially defined regions of 
pneumonic plague lung lesions  
Pulmonary infection of mice with Y. pestis results in the formation of distinct 
inflammatory lesions in the lung during the pro-inflammatory phase of disease. The 
lesions consist primarily of Y. pestis bacteria and densely packed pockets of 
neutrophils, and these inflamed sites expand throughout the duration of infection, 
ultimately covering entire lobes of the lung (Lathem et al., 2005). At 48 hours post-
inoculation (hpi) with Y. pestis strain CO92, we observed that a typical H&E-stained 
lung section contained up to 5 distinct foci of inflammation per lobe. These sites 
were as large as 3 mm in diameter, with inflammation occupying 5-10% of the total 
examined tissue plane (Figure 2.1A). The inflammatory infiltrate displayed very little 
cellular necrosis and was composed predominantly of neutrophils, with fewer 
dispersed macrophages. Interspersed amid inflammatory infiltrate were abundant 
extracellular organisms and variable amounts of fibrin, hemorrhage, edema, and 
cellular debris. The majority of large and small bronchi remained unaffected, even 
those located immediately adjacent to inflammatory foci. Occasional dense 
aggregates of extracellular bacteria formed small colonies, particularly at the 
periphery of lesions (Figure 2.1C). These observations suggested that I could learn 
more quantitative information from these lesions by spatially dissecting them to 
analyze unique microenvironments.  
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To further characterize these inflammatory lung lesions, I focused on 
analyzing transcriptional responses in neutrophils to understand the lack of turnover 
and clearance of this key cell type. The T3SS of Y. pestis has potent anti-
inflammatory effects on targeted mammalian cells (Aepfelbacher et al., 2007). As a 
result of their direct contact with Y. pestis, we predicted that those neutrophils found 
within the initiating focus of the lung lesions, the lesion “center,” would have a 
different transcriptional profile than those found in the lesion periphery, where I 
assumed the most recent wave of migrating neutrophils would be found. To test this, 
I devised an approach to identify transcriptionally regulated host pathways in 
neutrophils found within these spatially distinct regions. Briefly, I infected mice with 
104 CFU of Y. pestis CO92, a fully virulent strain previously isolated from a 
pneumonic plague patient. At 48 hpi I treated lungs with an RNA preservative, then 
used LCM on fixed and frozen sections to collect tissue from the center and 
periphery of the lesions (Figure 2.1D, E).   
Total RNA was isolated from these captured microenvironments, RNAseq 
libraries were prepared, and samples were sequenced to define host transcriptional 
responses. Additionally, I harvested total RNA from MACS-isolated neutrophils 
residing in the bone marrow (BM-PMNs) of Y. pestis-infected (and mock-infected) 
mice at 48 hpi for comparison. Using Student’s t-test, 976 genes were identified that 
were differentially expressed between the periphery and center of the lung lesions 
(p-value < 0.05). This analysis was simultaneously performed on the infected- and 
mock-infected-mouse BM-PMN samples. This comparison identified 3,198 genes 
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that were differentially expressed in BM-PMNs from infected mice compared to 
mock-infected mice. Importantly, transcriptionally altered BM-PMN genes represent 
neutrophil-specific responses to Y. pestis infection at 48 hpi, and are a heterologous 
tissue match to the lung lesion samples collected at the same time point during 
infection.  Matching genes in the lesion periphery/center comparison to those genes 
found in the BM-PMN comparison allowed me to narrow the lung lesion gene set to 
those genes regulated specifically in neutrophils rather than other cell types in the 
lung. The initial list of 976 genes was reduced to 224 genes that were differentially 
expressed in both the BM-PMN and lung lesion comparisons, with a significant 
enrichment value of p = 0.02 (Figure 2.2, Table 2.1). This confirms that there are 
transcriptional alterations in neutrophil genes between the lesion periphery and 
center, and establishes that Y. pestis causes a sustained change in neutrophil 
transcription at distinct locations in lung lesions. Interestingly, when the four 
conditions (infected BM-PMN, mock-infected BM-PMN, lesion periphery, lesion 
center) were clustered across samples, the differential expression patterns of the 
224 genes showed that (i) the BM-PMN from mock-infected mice and lesion center 
conditions clustered together, and (ii) the BM-PMN from Y. pestis-infected mice and 
lesion periphery conditions clustered together (Figure 2.2). This suggests that the 
neutrophils in the lesion center had a transcriptional pattern more similar to 
“unstimulated” bone marrow neutrophils, despite residing in a highly inflammatory 
microenvironment in the infected lungs. 
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2.4.2 Gene set analysis implications for lesion development and neutrophil 
fate.  
Using the Ingenuity® Pathway Analysis (IPA®) program (QIAGEN Redwood 
City) and the Molecular Signatures Database (Subramanian et al., 2005), we 
compiled various gene sets (Table 2.2) to analyze pathways for differential gene 
expression patterns between the lesion periphery and center. Density curves were 
generated based on the ratio of RNA expression estimates between the lesion 
periphery and lesion center (when there were more than three reads in both 
conditions). A Wilcoxon rank-sum test was performed comparing the log ratio 
distribution from the individual gene sets to the entire transcriptome, with the goal of 
identifying bias in specific gene sets.  
Based on the log ratio of lesion periphery compared to the center, there was a 
statistically significant shift for genes in “leukocyte migration” pathways compared to 
the entire transcriptome (Figure 2.3B). This shift indicates relatively lower expression 
in the center of lesions; i.e., the lesion centers show an overall down-regulation of 
genes in this list. In contrast, “general cell migration” genes showed no shift in the 
lesion periphery/center ratio compared to the entire transcriptome (Figure 2.3A, 
Table 2.2). These transcriptional comparisons in the “leukocyte migration” pathways 
suggest that newly infiltrating neutrophils are localized at the periphery of the 
expanding lesions, while the neutrophils at the center were likely recruited much 
earlier. The histopathological evidence in the lungs also supports this scenario. 
Centrally within inflammatory foci, neutrophils are densely packed, completely filling 
	   37	  
alveolar spaces and leading to loss of the alveolar septa. Peripherally there are 
fewer, loosely packed neutrophils with some remaining clear air space.  
We additionally evaluated whether neutrophil apoptosis/survival was being 
altered in the center of lung lesions, since this could explain continued neutrophil 
accumulation due to a lack of turnover in the lung. A set of genes representing 
various apoptosis pathways was compiled (Table 2.2) and showed a statistically 
significant shift in the lesion periphery/center ratio compared to the entire 
transcriptome, indicating a down regulation of genes in the apoptosis pathways in 
the lesion center (Figure 2.3C). Overlaying individual apoptotic genes from the 
density curve analysis with a p-value < 0.5 onto the IPA® “Apoptosis Signaling” 
pathway (QIAGEN) showed that small transcriptional changes throughout this 
pathway could result in decreased apoptosis in cells at the center of lung lesions 
(Figure 2.1). 
 
2.5 Discussion 
The work presented in this chapter describes a novel approach to examining 
bacterial pathogenesis, using LCM to dissect unique spatial phenotypes of tissue 
damage during infection in vivo that cannot be studied in vitro. I hypothesized that Y. 
pestis directly alters the ability of neutrophils to progress through their cellular life 
cycle, leading to a failure of clearance from the lungs. This lack of clearance likely 
leads to development of the continually expanding inflammatory lesions, causing 
significant pulmonary damage. In the work presented here, I show that RNAseq 
analysis after LCM is a viable technique to study host/pathogen interactions during 
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infection. Further, I can glean information about disease progression by spatially 
dissecting regions of inflammation and damage in vivo that could not be obtained 
through in vitro studies alone. In the future it will be beneficial to be able to perform 
dual RNAseq to obtain both the host and bacterial transcriptome simultaneously.  
The formation of lung lesions during pneumonic plague is well documented in 
several animal models (Adamovicz and Worsham, 2006; Agar et al., 2009; Anderson 
et al., 2009; Fellows et al., 2012; Koster et al., 2010; Lathem et al., 2005; Layton et 
al., 2011; Van Andel et al., 2008). In this study, I present the first analysis of how 
these lung lesions develop and persist during pneumonic plague. Further, I probe 
the transcriptomes of host cells in the periphery and center of these lesions in an 
effort to better understand this complex microenvironment. The resulting data 
indicated that within the lung lesions, there are spatially defined differences in gene 
expression. Due to the high concentration of Y. pestis targeted neutrophils within the 
lesions (Marketon et al., 2005; Pechous et al., 2013), I was most interested in 
dissecting out neutrophil-specific transcriptional responses. When performing LCM, 
non-neutrophil RNA would also be isolated and complicate the neutrophil-specific 
analysis I was seeking. To abrogate this, I isolated BM-PMNs from mock-infected 
and Y. pestis-infected mice at 48 hpi to generate a list of genes I could identify as 
neutrophil-regulated responses to Y. pestis infection. By this time during infection, Y. 
pestis has disseminated into the bloodstream (Lathem et al., 2005) and can even be 
detected in the bone marrow (Vagima et al., 2012). I anticipated that any BM-PMN 
genes responsive to Y. pestis infection might also be identified in neutrophils in the 
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lesion comparison. Analyzing the lesion periphery and lesion center gave me an 
unbiased list of differentially expressed genes between these two regions in any cell 
type present. Matching differentially expressed genes from the lesion 
periphery/center comparison to the same genes in the BM-PMN comparison resulted 
in a set of 224 genes we identified as likely neutrophil-specific transcriptional 
responses to Y. pestis infection. Using the BM-PMN list gave me confidence that the 
224 genes identified in both comparisons are indicating a significant alteration in 
neutrophil gene expression between the lesion periphery and center, as opposed to 
contaminating monocytic infiltrate or lung epithelium.  
In addition to analyzing differential expression between regions of lung 
lesions, I wanted to test the hypothesis that lesions develop from small initiating foci 
and continue expanding outward throughout the course of infection. Alternatively, 
neutrophils could be infiltrating randomly into the lesion space. To examine this, the 
RNAseq data was analyzed based on defined lists of genes involved in general cell 
migration and leukocyte-specific migration compared to the entire transcriptome. The 
density distribution of the ratios of genes in each list was analyzed comparing the 
lesion periphery to the lesion center. This distribution was then compared to the 
same distribution from the entire transcriptome. This statistical comparison helped 
evaluate if transcription of genes in each of the lists were being skewed compared to 
the entire transcriptome. I observed a statistically significant shift in the log ratio in 
the leukocyte migration gene set, indicating decreased transcription in the center of 
lung lesions; in contrast, no shift was observed for genes involved in general cell 
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migration. This implies that neutrophils in the center of lesions were recruited earlier 
during infection, and these cells subsequently decreased transcription of genes such 
as cytokine and cell-cell adhesion receptors that are necessary for chemotaxis and 
lung infiltration (Table 2.2).  
I also postulated that the lesions continue to expand over time as a result of 
Y. pestis-mediated alteration of neutrophil apoptosis and survival. The apoptotic 
pathways gene list was analyzed as described above. A significant shift in the log 
ratio distribution of the apoptosis gene set suggested that these pathways were 
down-regulated in the center of lesions compared to the periphery. Analyzing the 
RNAseq data at the pathway level allowed me to statistically evaluate how small 
changes in expression of pathway-related genes may manifest into greater changes 
downstream in the pathway, since individual genes in pathways did not always show 
discrete statistically significant differences (p < 0.05) between areas of the lesion. 
For example, caspases-8 and 9 both had non-significant p-values (< 0.5); Looking 
closer at where these caspases intersect in apoptosis signaling pathways, it can be 
observed how a transcriptional decrease in caspase-8 can prevent the activation of 
BID to tBID, ultimately preventing the release of proteins allowing for downstream 
caspase activation. Both caspases-8 and 9 are important for direct cleavage of 
caspase-3, the converging point of both the extrinsic and intrinsic apoptosis 
pathways (McCracken and Allen, 2014). The decrease in transcription of both of 
these initiator caspases is an additional downstream hindrance to apoptosis (Figure 
2.4).  
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In summary, I introduced a unique application of LCM technology to directly 
examine the spatially distinct microenvironments resulting from host-pathogen 
interactions during primary pneumonic plague. As a result, I was able to identify 
pathways that are regulated by the interaction of Y. pestis with neutrophils in lung 
lesions during pneumonic plague. The directionality of these transcriptional changes 
suggest that neutrophils build from small foci in the lungs, and the neutrophils that 
first interact with Y. pestis in the center of these lesions are hindered in initiating 
apoptosis. Further defining and characterizing mediators of the dramatic pulmonary 
inflammation that occurs during pneumonic plague will help in understanding the 
lethality of this disease and may contribute to our understanding of severe 
pulmonary infection with other respiratory pathogens. 
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2.6 Figures and Tables 
 
Figure 2.1: Lung lesion histology and laser capture microdissection of lesions  
Representative H&E stained sections of a Y. pestis-infected lung at 48 hpi, shown at 
different magnifications (A-C, scale bar equals 500, 50, and 20u μm respectively). 
(C) The green arrows indicate dense aggregates of Y. pestis. Representative images 
of a lung section (D) before and (E) after laser capture microdissection (scale bar 
equals 300 μm). The lung lesion (outlined in black) was identified and the periphery 
and center of the lesions were spatially defined (outlined in white). Laser cutting and 
pulse catapulting into a preservative resin selectively removed white-outlined lesion 
sections.  
 
A! B! C!
D! E!
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Figure 2.2: Clustered genes showing differential transcription 
A heatmap showing 224 genes differentially expressed in two comparisons (BM-
PMNs from mock-infected v. infected mice and lesion periphery v. center). The red 
and green colors represent an increase or decrease, respectively, relative to the 
median value of each of the two initial comparisons. The X-axis clustering shows 
that all triplicates clustered together and that mock-infected BM-PMN and lesion 
Uninfected 
BM-PMN 
Lesion 
Periphery 
Lesion 
Center 
Infected 
BM-PMN 
UB UB UB LC LC LC IB IB IB LP LP LP
Usp20|74270Csrp2bp|228714Rpap1|68925
Pskh1|244631Kcnk6|52150Zfp526|210172
Ebna1bp2|69072Fen1|14156Nat10|98956
Kalrn|545156Nol11|68979Nolc1|70769
Scly|50880Slc10a3|214601Cenpf|108000
Elp2|58523Ctla2a|13024Naip6|17952
Polr3e|26939Trerf1|224829Acd|497652
Camsap1|227634Cdipt|52858Ttk|22137
Ppan|235036Zfp64|227224933427D14Rik|74477
Ndst2|17423Tmem229b|268567Ctcf|13018
Nek7|59125Tmem67|329795Zfp955b|100043468
Adam9|11502Hdlbp|110611Rnft1|76892
2610101N10Rik|67958M6pr|17113Eif3i|54709
Tbp|21374Zfp192|93681Ptpn4|19258
Phc3|241915Slfn9|237886BC016423|105203
Npat|244879Brix1|67832Zcchc4|78796
Mrps25|64658Nol8|70930Fundc2|67391
Slfn3|20557Dbi|13167Syncrip|56403
Impa1|55980Nup88|19069Rlim|19820
2210018M11Rik|233545Gclc|14629Eltd1|170757
F630043A04Rik|219114Dock4|238130Psd3|234353
Prpf40a|56194Chd9|109151Mysm1|320713
Sub1|20024Snapc3|77634Senp1|223870
Cir1|66935Rbpj|19664Piga|18700
Clock|12753Pigy|66459Serbp1|66870
Arl4a|11861Golm1|105348Pecam1|18613
Pdia6|71853Timp3|21859Pphln1|223828
Abi2|329165Cwc27|67285Rbmxl1|19656
Zfp187|432731Slc31a1|20529Vwf|22371
Esco1|77805Eif1a|13664Zfp280c|208968
Zeb1|21417Las1l|76130Rpl36al|66483
Ly6e|17069Ogdh|18293Sugt1|67955
Yipf6|77929Pde5a|242202A730017L22Rik|613258
Bpnt1|23827Rif1|51869Il6st|16195
Atp5o|28080Il15ra|16169Snrpd1|20641
Atl3|109168Zfp207|22680Fubp1|51886
Fmr1|14265Sec63|140740Ahi1|52906
Ube2j1|56228Rrm2b|382985Tmem167|66074
Rnf144b|218215Trove2|20822Gpr65|14744
Dhx15|13204Qrich1|69232C1ra|50909
Anxa4|11746Stt3a|16430Beta−s|100503605
Lpar6|67168Gpx3|14778Cfh|12628
Ghitm|66092Gnpnat1|54342Pmm2|54128
Sf3a1|67465Ddx46|212880Lrp6|16974
Mtpn|14489Orm1|18405Ceacam1|26365
Tra2b|20462Prpf39|328110Canx|12330
Slc43a3|58207Golim4|73124Vcam1|22329
Zbtb20|564909030624J02Rik|71517H2−T24|15042
Rin2|74030Cdc37l1|67072Arrb1|109689
Mylip|218203Hmg20a|66867Il28ra|242700
Maz|17188Arrdc3|105171Cep350|74081
Ngly1|59007Atp2c1|235574Utrn|22288
Kif1b|16561Nt5e|23959Ddx17|67040
Ankrd44|329154Mtap4|17758Phf20l1|239510
Bmpr1a|12166Rps15a|267019A930001N09Rik|77128
Aftph|216549Gnb1|14688Slc12a6|107723
Slc44a1|100434Ube3a|22215Ralgapa2|241694
Rtf1|76246Dlg1|13383BC005537|79555
Smek1|68734Cd47|16423Rbm33|381626
Rap1gds1|229877Slmap|83997Sptlc2|20773
Ghdc|80860Smcr7|237781Slc38a10|72055
Tmem8|60455Gatad2b|229542Tpcn1|252972
Tubgcp6|3285802310021P13Rik|268721Pcnxl3|104401
Cln3|12752Wdfy4|545030Fkrp|243853
2410016O06Rik|71952Clta|12757Plec|18810
Nat8l|269642Sipa1l2|244668Triobp|110253
Itprip|414801Scaf1|233208Ubn1|170644
Prr12|233210Stx2|13852Fam40a|229707
Sytl1|269589Lmnb1|16906Klhl25|207952
Lrrc61|243371Sec22c|215474Cd101|630146
Rnf145|743151700020L24Rik|66330Fam193b|212483
Zfp516|329003Zfp710|209225Agrn|11603
Ankrd33b|67434Crlf3|54394A830007P12Rik|227612
Arhgap23|58996Btbd19|78611Zc3h12d|237256
Fam102a|98952Nipal3|74552
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center samples clustered more closely, as did infected BM-PMN and lesion 
periphery samples. Each gene shows significant differences (p < 0.05 in Student’s t-
test) in each of the two initial comparisons. The blue, orange, yellow, and purple 
colored bars represent the four possible outcomes of gene regulation comparisons 
(e.g., blue bar shows genes that were decreased in BM-PMNs from infected 
compared to mock-infected mice and increased in the lesion center compared to the 
periphery). 
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Figure 2.3: Density curves of defined gene sets compared to the entire 
transcriptome 
Gene sets were compiled to represent A) general cell migration, B) leukocyte 
migration, and C) apoptosis pathways. Using the log ratio of RNAseq reads in lesion 
periphery compared to lesion center, log ratios of each of these compiled gene sets 
(blue lines) were contrasted against the entire transcriptome (grey lines) using a 
Wilcoxon rank-sum test. The Y-axis values are arbitrary units as calculated by 
Gaussian kernel density estimates. Only genes with > 3 reads from the RNAseq 
analysis were graphed.   
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Figure 2.4: Ingenuity® Pathway Analysis “Apoptosis Signaling” pathway 
overlaid with relevant genes from density curve analysis 
Genes from the “Apoptosis Signaling” pathway from IPA® were included in the 
“Apoptosis genes” list used in the density curve analysis. The density curve analysis 
identified the “Apoptosis genes” list as being transcriptionally decreased in the 
Cytoplasm*
Extracellular*space*
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center of lesions so individual genes with p < 0.5 were overlaid onto the IPA® 
“Apoptosis Signaling” pathway (green) to visually represent small transcriptional 
changes throughout the pathway in the center of lesions. Red lines represent direct 
interactions that would be affected by decreased transcription of identified genes in 
cells. Orange lines represent secondary affects of the identified genes being down-
regulated in cells. 
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Table 2.1: List of 224 differentially regulated in both the infected versus 
uninfected BM-PMN and lesion periphery versus center comparisons 
Gene names Entrez numbers 
p-value 
(infected/uninfected 
BM-PMN) 
p-value        
(lesion 
periphery/center) 
Pattern of 
differential 
expression 
1700020L24Rik 
2210018M11Rik 
2310021P13Rik 
2410016O06Rik 
2610101N10Rik 
4933427D14Rik 
9030624J02Rik 
A730017L22Rik 
A830007P12Rik 
A930001N09Rik 
Abi2 
Acd 
Adam9 
Aftph 
Agrn 
Ahi1 
Ankrd33b 
Ankrd44 
Anxa4 
Arhgap23 
Arl4a 
Arrb1 
Arrdc3 
Atl3 
Atp2c1 
Atp5o 
BC005537 
BC016423 
Beta-s 
Bmpr1a 
Bpnt1 
Brix1 
Btbd19 
C1ra 
Camsap1 
Canx 
Cd101 
Cd47 
Cdc37l1 
Cdipt 
66330 
233545 
268721 
71952 
67958 
74477 
71517 
613258 
227612 
77128 
329165 
497652 
11502 
216549 
11603 
52906 
67434 
329154 
11746 
58996 
11861 
109689 
105171 
109168 
235574 
28080 
79555 
105203 
100503605 
12166 
23827 
67832 
78611 
50909 
227634 
12330 
630146 
16423 
67072 
52858 
1.785E-03 
2.390E-03 
1.884E-03 
2.340E-05 
2.148E-03 
8.521E-05 
3.365E-04 
8.267E-04 
1.342E-04 
1.181E-04 
5.410E-04 
1.457E-04 
3.363E-04 
2.212E-03 
1.651E-03 
4.990E-05 
2.271E-03 
1.774E-03 
2.192E-03 
2.015E-03 
1.610E-04 
2.618E-03 
1.206E-03 
2.172E-04 
4.490E-05 
2.394E-03 
3.890E-04 
1.190E-04 
1.571E-03 
2.208E-04 
5.592E-04 
3.344E-06 
5.192E-04 
1.083E-03 
7.791E-04 
1.442E-03 
2.684E-03 
2.823E-03 
3.366E-05 
1.810E-03 
3.813E-02 
4.503E-02 
3.917E-02 
1.943E-03 
4.178E-02 
4.736E-03 
1.289E-02 
2.235E-02 
6.709E-03 
6.266E-03 
1.674E-02 
7.469E-03 
1.278E-02 
4.287E-02 
3.675E-02 
3.264E-03 
4.341E-02 
3.806E-02 
4.258E-02 
4.055E-02 
7.882E-03 
4.751E-02 
2.863E-02 
9.122E-03 
3.082E-03 
4.508E-02 
1.354E-02 
6.309E-03 
3.535E-02 
9.151E-03 
1.717E-02 
4.679E-04 
1.603E-02 
2.650E-02 
2.172E-02 
3.324E-02 
4.791E-02 
4.935E-02 
2.394E-03 
3.837E-02 
blue 
yellow 
blue 
blue 
yellow 
purple 
orange 
yellow 
blue 
orange 
yellow 
purple 
yellow 
orange 
blue 
yellow 
blue 
orange 
yellow 
blue 
yellow 
orange 
orange 
yellow 
orange 
yellow 
orange 
yellow 
yellow 
orange 
yellow 
yellow 
blue 
yellow 
purple 
yellow 
blue 
orange 
orange 
purple 
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Ceacam1 
Cenpf 
Cep350 
Cfh 
Chd9 
Cir1 
Cln3 
Clock 
Clta 
Crlf3 
Csrp2bp 
Ctcf 
Ctla2a 
Cwc27 
Dbi 
Ddx17 
Ddx46 
Dhx15 
Dlg1 
Dock4 
Ebna1bp2 
Eif1a 
Eif3i 
Elp2 
Eltd1 
Esco1 
F630043A04Rik 
Fam102a 
Fam193b 
Fam40a 
Fen1 
Fkrp 
Fmr1 
Fubp1 
Fundc2 
Gatad2b 
Gclc 
Ghdc 
Ghitm 
Gnb1 
Gnpnat1 
Golim4 
Golm1 
Gpr65 
Gpx3 
H2-T24 
26365 
108000 
74081 
12628 
109151 
66935 
12752 
12753 
12757 
54394 
228714 
13018 
13024 
67285 
13167 
67040 
212880 
13204 
13383 
238130 
69072 
13664 
54709 
58523 
170757 
77805 
219114 
98952 
212483 
229707 
14156 
243853 
14265 
51886 
67391 
229542 
14629 
80860 
66092 
14688 
54342 
73124 
105348 
14744 
14778 
15042 
1.634E-03 
2.396E-03 
4.066E-04 
2.824E-04 
9.402E-05 
2.450E-03 
6.450E-07 
1.731E-03 
6.241E-05 
2.848E-03 
5.572E-04 
1.609E-04 
3.487E-04 
8.800E-05 
5.053E-04 
1.248E-03 
1.074E-03 
1.771E-03 
1.551E-05 
1.785E-03 
3.270E-05 
1.037E-03 
5.940E-04 
2.920E-04 
1.341E-03 
1.697E-04 
1.566E-03 
1.886E-03 
6.371E-04 
2.790E-04 
5.300E-04 
8.457E-04 
4.797E-04 
1.234E-03 
1.828E-06 
1.288E-03 
3.705E-05 
2.727E-04 
4.152E-04 
2.041E-03 
5.198E-04 
8.254E-04 
9.266E-05 
5.077E-04 
1.257E-04 
1.869E-03 
3.623E-02 
4.514E-02 
1.387E-02 
1.152E-02 
5.200E-03 
4.566E-02 
3.500E-05 
3.785E-02 
3.622E-03 
4.942E-02 
1.713E-02 
7.860E-03 
1.297E-02 
5.039E-03 
1.593E-02 
2.958E-02 
2.643E-02 
3.803E-02 
1.377E-03 
3.819E-02 
2.229E-03 
2.609E-02 
1.817E-02 
1.180E-02 
3.110E-02 
7.903E-03 
3.526E-02 
3.923E-02 
1.892E-02 
1.145E-02 
1.651E-02 
2.276E-02 
1.562E-02 
2.944E-02 
3.273E-04 
3.001E-02 
2.631E-03 
1.110E-02 
1.412E-02 
4.077E-02 
1.605E-02 
2.217E-02 
5.169E-03 
1.593E-02 
6.321E-03 
3.906E-02 
yellow 
purple 
orange 
yellow 
yellow 
yellow 
blue 
yellow 
blue 
blue 
purple 
yellow 
purple 
yellow 
yellow 
orange 
yellow 
yellow 
orange 
yellow 
purple 
yellow 
yellow 
purple 
yellow 
yellow 
yellow 
blue 
blue 
blue 
purple 
blue 
yellow 
yellow 
yellow 
blue 
yellow 
blue 
yellow 
orange 
yellow 
orange 
yellow 
yellow 
yellow 
orange 
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Hdlbp 
Hmg20a 
Il15ra 
Il28ra 
Il6st 
Impa1 
Itprip 
Kalrn 
Kcnk6 
Kif1b 
Klhl25 
Las1l 
Lmnb1 
Lpar6 
Lrp6 
Lrrc61 
Ly6e 
M6pr 
Maz 
Mrps25 
Mtap4 
Mtpn 
Mylip 
Mysm1 
Naip6 
Nat10 
Nat8l 
Ndst2 
Nek7 
Ngly1 
Nipal3 
Nol11 
Nol8 
Nolc1 
Npat 
Nt5e 
Nup88 
Ogdh 
Orm1 
Pcnxl3 
Pde5a 
Pdia6 
Pecam1 
Phc3 
Phf20l1 
Piga 
110611 
66867 
16169 
242700 
16195 
55980 
414801 
545156 
52150 
16561 
207952 
76130 
16906 
67168 
16974 
243371 
17069 
17113 
17188 
64658 
17758 
14489 
218203 
320713 
17952 
98956 
269642 
17423 
59125 
59007 
74552 
68979 
70930 
70769 
244879 
23959 
19069 
18293 
18405 
104401 
242202 
71853 
18613 
241915 
239510 
18700 
1.695E-03 
2.798E-04 
2.239E-04 
2.156E-03 
1.909E-04 
3.539E-05 
2.792E-03 
2.950E-04 
2.365E-03 
1.276E-03 
8.177E-04 
4.798E-05 
2.632E-03 
4.162E-04 
1.936E-03 
6.254E-05 
1.917E-03 
4.919E-04 
1.468E-03 
7.352E-04 
1.368E-03 
1.020E-04 
1.128E-03 
2.689E-03 
2.473E-04 
5.594E-04 
1.498E-04 
1.064E-04 
2.560E-03 
1.790E-03 
2.578E-03 
2.463E-03 
2.834E-03 
1.704E-03 
3.345E-04 
6.090E-05 
9.513E-04 
1.139E-04 
8.525E-04 
9.165E-05 
5.994E-04 
1.859E-03 
1.219E-03 
1.428E-04 
1.113E-03 
6.141E-05 
3.753E-02 
1.150E-02 
9.260E-03 
4.202E-02 
8.574E-03 
2.513E-03 
4.904E-02 
1.197E-02 
4.481E-02 
2.989E-02 
2.207E-02 
3.210E-03 
4.759E-02 
1.417E-02 
3.994E-02 
3.634E-03 
3.985E-02 
1.567E-02 
3.373E-02 
2.069E-02 
3.200E-02 
5.410E-03 
2.698E-02 
4.828E-02 
1.022E-02 
1.751E-02 
7.494E-03 
5.747E-03 
4.696E-02 
3.825E-02 
4.713E-02 
4.574E-02 
4.937E-02 
3.768E-02 
1.267E-02 
3.585E-03 
2.431E-02 
6.009E-03 
2.302E-02 
5.139E-03 
1.823E-02 
3.881E-02 
2.920E-02 
7.247E-03 
2.677E-02 
3.598E-03 
yellow 
orange 
yellow 
orange 
yellow 
yellow 
blue 
purple 
purple 
orange 
blue 
yellow 
blue 
yellow 
yellow 
blue 
yellow 
yellow 
orange 
yellow 
orange 
yellow 
orange 
yellow 
purple 
purple 
blue 
purple 
yellow 
orange 
blue 
purple 
yellow 
purple 
yellow 
orange 
yellow 
yellow 
yellow 
blue 
yellow 
yellow 
yellow 
yellow 
orange 
yellow 
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Pigy 
Plec 
Pmm2 
Polr3e 
Ppan 
Pphln1 
Prpf39 
Prpf40a 
Prr12 
Psd3 
Pskh1 
Ptpn4 
Qrich1 
Ralgapa2 
Rap1gds1 
Rbm33 
Rbmxl1 
Rbpj 
Rif1 
Rin2 
Rlim 
Rnf144b 
Rnf145 
Rnft1 
Rpap1 
Rpl36al 
Rps15a 
Rrm2b 
Rtf1 
Scaf1 
Scly 
Sec22c 
Sec63 
Senp1 
Serbp1 
Sf3a1 
Sipa1l2 
Slc10a3 
Slc12a6 
Slc31a1 
Slc38a10 
Slc43a3 
Slc44a1 
Slfn3 
Slfn9 
Slmap 
66459 
18810 
54128 
26939 
235036 
223828 
328110 
56194 
233210 
234353 
244631 
19258 
69232 
241694 
229877 
381626 
19656 
19664 
51869 
74030 
19820 
218215 
74315 
76892 
68925 
66483 
267019 
382985 
76246 
233208 
50880 
215474 
140740 
223870 
66870 
67465 
244668 
214601 
107723 
20529 
72055 
58207 
100434 
20557 
237886 
83997 
4.350E-04 
1.644E-03 
2.884E-03 
1.820E-03 
1.584E-03 
5.886E-04 
3.325E-04 
3.789E-04 
2.271E-05 
8.944E-04 
5.221E-04 
4.970E-04 
6.860E-04 
2.762E-04 
2.586E-03 
1.304E-03 
2.387E-04 
1.376E-04 
2.219E-03 
1.648E-03 
4.269E-04 
1.444E-04 
1.145E-04 
5.695E-04 
1.643E-03 
1.841E-03 
6.438E-04 
3.912E-04 
1.117E-03 
8.171E-05 
1.031E-03 
8.462E-04 
4.979E-04 
1.393E-03 
7.059E-04 
1.305E-03 
1.016E-04 
1.627E-03 
1.127E-03 
9.491E-04 
2.215E-04 
1.613E-03 
1.165E-03 
4.833E-06 
2.525E-03 
2.683E-04 
1.497E-02 
3.661E-02 
4.979E-02 
3.841E-02 
3.551E-02 
1.813E-02 
1.256E-02 
1.320E-02 
1.894E-03 
2.379E-02 
1.613E-02 
1.574E-02 
1.987E-02 
1.133E-02 
4.734E-02 
3.015E-02 
9.591E-03 
6.919E-03 
4.302E-02 
3.664E-02 
1.471E-02 
7.281E-03 
6.080E-03 
1.785E-02 
3.648E-02 
3.873E-02 
1.916E-02 
1.375E-02 
2.689E-02 
4.572E-03 
2.593E-02 
2.279E-02 
1.576E-02 
3.250E-02 
2.012E-02 
3.016E-02 
5.384E-03 
3.609E-02 
2.692E-02 
2.423E-02 
9.159E-03 
3.594E-02 
2.744E-02 
6.037E-04 
4.653E-02 
1.087E-02 
yellow 
blue 
yellow 
purple 
purple 
yellow 
yellow 
yellow 
blue 
yellow 
purple 
yellow 
yellow 
orange 
orange 
orange 
yellow 
yellow 
yellow 
orange 
yellow 
yellow 
blue 
yellow 
purple 
yellow 
orange 
yellow 
orange 
blue 
purple 
blue 
yellow 
yellow 
yellow 
yellow 
blue 
purple 
orange 
yellow 
blue 
yellow 
orange 
yellow 
yellow 
orange 
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Smcr7 
Smek1 
Snapc3 
Snrpd1 
Sptlc2 
Stt3a 
Stx2 
Sub1 
Sugt1 
Syncrip 
Sytl1 
Tbp 
Timp3 
Tmem167 
Tmem229b 
Tmem67 
Tmem8 
Tpcn1 
Tra2b 
Trerf1 
Triobp 
Trove2 
Ttk 
Tubgcp6 
Ube2j1 
Ube3a 
Ubn1 
Usp20 
Utrn 
Vcam1 
Vwf 
Wdfy4 
Yipf6 
Zbtb20 
Zc3h12d 
Zcchc4 
Zeb1 
Zfp187 
Zfp192 
Zfp207 
Zfp280c 
Zfp516 
Zfp526 
Zfp64 
Zfp710 
Zfp955b 
237781 
68734 
77634 
20641 
20773 
16430 
13852 
20024 
67955 
56403 
269589 
21374 
21859 
66074 
268567 
329795 
60455 
252972 
20462 
224829 
110253 
20822 
22137 
328580 
56228 
22215 
170644 
74270 
22288 
22329 
22371 
545030 
77929 
56490 
237256 
78796 
21417 
432731 
93681 
22680 
208968 
329003 
210172 
22722 
209225 
100043468 
2.532E-04 
2.066E-05 
1.707E-03 
1.607E-03 
1.205E-03 
2.715E-03 
6.584E-04 
1.393E-03 
2.735E-04 
2.175E-03 
5.621E-04 
2.555E-04 
1.904E-03 
7.523E-04 
2.096E-04 
1.155E-04 
8.552E-04 
3.229E-04 
2.422E-03 
1.483E-03 
1.482E-03 
1.740E-03 
9.224E-05 
1.411E-04 
9.973E-04 
1.244E-03 
1.102E-03 
2.059E-03 
2.157E-03 
1.360E-03 
1.093E-03 
2.603E-04 
1.027E-05 
1.257E-03 
2.045E-03 
9.434E-04 
1.783E-03 
2.101E-04 
5.407E-05 
1.306E-03 
2.246E-03 
1.144E-03 
9.628E-04 
7.049E-07 
8.023E-04 
4.244E-04 
1.039E-02 
1.865E-03 
3.774E-02 
3.590E-02 
2.851E-02 
4.842E-02 
1.935E-02 
3.246E-02 
1.126E-02 
4.235E-02 
1.752E-02 
1.057E-02 
3.947E-02 
2.083E-02 
8.968E-03 
6.114E-03 
2.312E-02 
1.227E-02 
4.552E-02 
3.409E-02 
3.403E-02 
3.788E-02 
5.162E-03 
7.009E-03 
2.499E-02 
2.954E-02 
2.654E-02 
4.101E-02 
4.211E-02 
3.141E-02 
2.653E-02 
1.065E-02 
9.813E-04 
2.970E-02 
4.078E-02 
2.416E-02 
3.808E-02 
9.036E-03 
3.348E-03 
3.020E-02 
4.317E-02 
2.729E-02 
2.449E-02 
6.244E-05 
2.187E-02 
1.446E-02 
blue 
orange 
yellow 
yellow 
orange 
yellow 
blue 
yellow 
yellow 
yellow 
blue 
yellow 
yellow 
yellow 
purple 
yellow 
blue 
blue 
yellow 
purple 
blue 
yellow 
purple 
blue 
yellow 
orange 
blue 
purple 
orange 
orange 
yellow 
blue 
yellow 
orange 
blue 
yellow 
yellow 
yellow 
yellow 
yellow 
yellow 
blue 
purple 
purple 
blue 
yellow 
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Table 2.2: Gene composition of lists used for density curve analysis 
General cell migration                                   Molecular Signatures Database * 
ABI2 
ABI3 
ACVRL1 
AIMP1 
ALOX15B 
AMOT 
ANG 
ANGPTL3 
ARAP3 
AZU1 
BCAR1 
BMP10 
CALCA 
CCDC88A 
CD24 
CD2AP 
CD34 
CDH13 
CDK5R1 
CKLF 
CLIC4 
CNTN4 
CX3CL1 
CXCR2 
DOCK2 
DPYSL5 
EGFR 
ENPEP 
FEZ1 
FEZ2 
GDNF 
GLI2 
GTPBP4 
HMGCR 
IL10 
IL12A 
IL12B 
IL8 
ITGB1 
ITGB1BP1 
ITGB2 
KAL1 
KRT2 
LAMB1 
LAMC1 
MDGA1 
MIA3 
MYH9 
NEXN 
NF1 
NF2 
NRD1 
NRP1 
NRP2 
NRTN 
NRXN1 
NRXN3 
OPHN1 
OTX2 
PARD6B 
PARP9 
PF4 
PLG 
PPAP2A 
PPAP2B 
PRSS3 
PTEN 
RTN4 
S100A2 
S100P 
SAA1 
SCG2 
SEMA3B 
SEMA4F 
SFTPD 
SHH 
SHROOM2 
SIAH1 
SLIT1 
SLIT2 
SPHK1 
SPON2 
SYK 
TBX5 
TDGF1 
TGFB2 
THBS4 
THY1 
TNFSF12 
TNN 
TRIP6 
UBB 
UNC5C 
VCL 
VEGFC 
WNT1 
Leukocyte migration                                     Molecular Signatures Database ** 
ACTB 
ACTG1 
ACTN1 
ACTN2 
ACTN3 
ACTN4 
AIMP1 
ARHGAP35 
ARHGAP5 
BCAR1 
CD34 
CD99 
CDC42 
CDH5 
CKLF 
CLDN1 
CLDN10 
CLDN11 
CLDN14 
CLDN15 
CLDN16 
CLDN17 
CLDN18 
CLDN19 
CLDN2 
CLDN20 
CLDN22 
CLDN23 
CLDN3 
CLDN4 
CLDN5 
CLDN6 
CLDN7 
CLDN8 
CLDN9 
CTNNA1 
CTNNA2 
CTNNA3 
CTNNB1 
CTNND1 
CX3CL1 
CXCL1 
CXCL12 
CXCL2 
CXCR1 
CXCR2 
CXCR2 
CXCR4 
CYBA 
CYBB 
DOCK2 
ESAM 
EZR 
F11R 
GNAI1 
GNAI2 
GNAI3 
ICAM1 
IL10 
IL8 
ITGA4 
ITGAL 
ITGAM 
ITGB1 
ITGB2 
ITGB2 
ITK 
JAM2 
JAM3 
LOC100418883 
LOC646821 
MAPK11 
MAPK12 
MAPK13 
MAPK14 
MIA3 
MLLT4 
MMP2 
MMP9 
MSN 
MYL10 
MYL12A 
MYL12B 
MYL2 
MYL5 
MYL7 
MYL9 
MYLPF 
NCF1 
NCF2 
NCF4 
NOX1 
NOX3 
OCLN 
PECAM1 
PF4 
PIK3CA 
PIK3CB 
PIK3CD 
PIK3CG 
PIK3R1 
PIK3R2 
PIK3R3 
PIK3R5 
PLCG1 
PLCG2 
PRKCA 
PRKCB 
PRKCG 
PTK2 
PTK2B 
PTPN11 
PXN 
RAC1 
RAC2 
RAP1A 
RAP1B 
RAPGEF3 
RAPGEF4 
RASSF5 
RHOA 
RHOH 
ROCK1 
ROCK2 
SAA1 
SCG2 
SFTPD 
SIPA1 
SYK 
TGFB2 
THY1 
TXK 
VASP 
VAV1 
VAV2 
VAV3 
VCAM1 
VCL 
Apoptosis pathways                                       Ingenuity® Pathway Analysis *** 
ACIN1 
AIMF1 
Akt 
APAF1 
BAD 
BAK1 
BAX 
BCL2 
BCL2A1 
BCL2L1 
BCL2L10 
BCL2L11 
BID 
BIRC6 
CASP10 
CASP12 
CASP2 
CASP3 
CASP6 
CASP7 
CASP8 
CASP9 
CDK1 
CDKN2A 
Ciap 
CYCS 
DFFA 
DFFB 
DIABLO 
ENDOG 
ERK1 
ERK2 
FADD 
FAS 
FASLG 
GAS2 
GRB2 
GTRA2 
IGF1 
IGF1R 
IkB 
IKK 
Jnk 
Jnkk 
LMNA 
MAP2K1 
MAP2K2 
MAP3K5 
MAPK8 
MCL1 
MYC 
NFkB 
NIK 
PARP1 
PI3K 
PKC 
PLC 
RAF1 
Ras 
ROCK1 
RPS6ka1 
SHC1 
Sos 
SPTAN1 
TNF 
TP53 
* - Compiled from the Molecular Signatures Database (Subramanian et al., 2005) “KEGG Leukocyte Transendothelial 
Migration” (http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION.html) 
and “Gene Ontology Leukocyte Migration” (http://www.broadinstitute.org/gsea/msigdb/cards/LEUKOCYTE_MIGRATION.html) 
pathways.  
** - From the Molecular Signatures Database (Subramanian et al., 2005) from the “Gene Ontology Cell Migration” 
(http://www.broadinstitute.org/gsea/msigdb/cards/CELL_MIGRATION.html) pathway   
*** - Compiled using Ingenuity® Pathway Analysis program from the “Apoptosis Signaling” and “Myc Mediated Apoptosis” 
pathways (QIAGEN Redwood City) 
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CHAPTER 3: INDUCTION OF NETUROPHIL SURVIVAL BY Yersinia pestis 
THROUGH THE TYPE III SECRETION SYSTEM EFFECTOR YopM† 
 
3.1 Overview 
 This Chapter describes the ability of Yersinia pestis to prolong the survival of 
neutrophils, which may lead to more severe pneumonia due to the prolonged 
accumulation of neutrophils in the lower respiratory tract. Global transcriptional 
analysis in defined lesion microenvironments from Chapter 2 is used as a foundation 
for in vitro and in vivo characterization of neutrophils during a Y. pestis infection. 
These studies provide evidence that Y. pestis promotes neutrophil survival and 
inhibits apoptosis in a novel type III secretion system (T3SS) effector-dependent 
manner. By determining how Y. pestis alters neutrophil lifespan and induces unique 
transcriptional responses within sites of infection, we will better understand the 
mechanisms by which neutrophils typically work in a broad range of diseases in 
which neutrophil infiltration becomes harmful to the host.   
 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
† This data has been published in: Stasulli NM, Eichelberger KR, Price PA, Pechous 
RD, Montgomery SA, Parker JS, Goldman WE. 2015. Spatially distinct neutrophil 
responses within the inflammatory lesions of pneumonic plague. mBio 6(5):e01530-
15. doi:10.1128/mBio.01530-15.	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3.2 Introduction 
While there are many genetic mutations and insertions that differentiate the 
three pathogenic species of Yersinia (enterocolitica, pseudotuberculosis, and pestis) 
there are several shared virulence plasmids and genomic islands that are vital for 
virulence (Perry and Fetherston, 1997; Wren, 2003). Three of these virulence 
determinants important during pneumonic plague are the pCD1 plasmid (Ben-Gurion 
and Shafferman, 1981), the genomic pigmentation locus (pgm) (Jackson and 
Burrows, 1956), and the pla gene encoded on the pPCP1 plasmid (Sodeinde et al., 
1988).  
The pCD1 plasmid (known as pYV in Y. pseudotuberculosis and Y. 
enterocolitica) is a common ancestral virulence factor for all three pathogenic 
Yersinia species (Wren, 2003). The acquisition of the pCD1 plasmid gave non-
pathogenic environmental yersiniae the ability to transcribe genes for the functional 
needle complex of a T3SS, along with effector proteins that are injected by this 
apparatus (Cornelis et al., 1998). Despite the lack of an identified receptor for the Y. 
pestis T3SS, it appears to have an affinity for injecting innate immune cells during 
infection (Marketon et al., 2005; Pechous et al., 2013). Early during pneumonic 
plague, macrophages are the most frequently injected cell type. However, as 
neutrophils being to infiltrate the alveolar spaces they are preferentially injected by 
the Y. pestis T3SS (Pechous et al., 2013). While each Yop effector has unique 
functions and may act in different compartments of the cell, the global cell effects 
overlap to ultimately suppress innate immune anti-microbial functions. The effector 
YopE is a GTPase activating protein that leads to the inactivation of Rho and Rac 
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GTP binding proteins (Aepfelbacher et al., 2007). This results in the blocking of 
phagocytosis and inhibition of reactive oxygen species (ROS) production of several 
cell types including neutrophils (Ruckdeschel et al., 1996). The effector YopH is a 
tyrosine phosphatase that primarily dephosphorylates focal adhesion proteins. This 
effector, similar to YopE, results in decreased phagocytosis in various cell types and 
an inhibition of ROS generation in neutrophils (Aepfelbacher et al., 2007; 
Ruckdeschel et al., 1996). The effector YopJ/P is a serine/threonine 
acetyltransferase that has been shown to act on MAPK kinases and IκB kinase-β. 
This transferase activity has been shown to be important for dampening the immune 
response and promoting apoptosis of macrophages (Trosky et al., 2008). 
Interestingly, however, neutrophils are resistant to YopJ/P-induced apoptosis 
(Spinner et al., 2010). The effector YopM has no known enzymatic function. Rather, 
it has been shown to have protein-protein binding functions. While the global cellular 
effects of its scaffolding are not clear, it has been shown to be important for full 
virulence during bubonic plague (Trosky et al., 2008). The effector YopO (YpkA) has 
been shown to have multiple functions. YopO is a serine/threonine kinase that can 
auto-phosphorylate upon binding actin, disrupt the actin cytoskeleton, and has 
guanidine nucleotide dissociation inhibitor activity. While its function during plague 
pathogenesis is not fully understood, it has been shown to promote apoptosis in 
macrophages (Park et al., 2007), hinder phagocytosis, and it has been suggested 
that it may be the cause of the abnormal bleeding experienced during plague 
(Navarro et al., 2007; Trosky et al., 2008). The effector YopT is a cysteine protease 
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that targets Rho GTPases attached to an isoprenoid moiety. It has been shown to 
mildly inhibit phagocytosis and interfere with actin assembly in various cells including 
neutrophils (Aepfelbacher et al., 2007).  
After acquiring the pCD1 virulence plasmid, two distinct species of Yersinia 
evolved, Y. enterocolitica and Y. pseudotuberculosis. One virulence factor that 
distinguishes these two species is the pgm locus that was acquired by Y. 
pseudotuberculosis (Wren, 2003). This locus contains two distinct gene islands: The 
first contains the genes necessary for the production and utilization of yersiniabactin, 
a small siderophore that sequesters host iron. The second island contains a 
somewhat random assortment of genes necessary for biofilm formation and flea 
transmission of Y. pestis to a mammalian host (Bearden et al., 1997; Buchrieser et 
al.; Hinnebusch et al., 1996). While regions of the pgm locus are necessary for full 
virulence in both bubonic and pneumonic plague (Fetherston et al., 2010; 
Hinnebusch et al., 1996), it is possible to complement a deletion of the pgm locus 
and restore pathogenesis during bubonic plague in an infected individual with 
elevated levels of iron (Quenee et al., 2012). 
The final of these three virulence factors to be acquired was the pla gene via 
acquisition of the pPCP1 plasmid. The presence of pla is one of the factors that 
uniquely distinguishes Y. pestis from Y. pseudotuberculosis (Sodeinde et al., 1988; 
Wren, 2003). Pla is necessary for the development of both bubonic and pneumonic 
plague (Lathem et al., 2007; Perry and Fetherston, 1997). The pla gene encodes a 
protease that cleaves plasminogen into active plasmin that can degrade fibrin clots 
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(Perry and Fetherston, 1997). Pla is described as a promiscuous protease and can 
cleave many components of the plasminogen pathway, complement proteins, outer 
membrane proteins, and Fas ligand. There are also indications that it can act as an 
adhesin in addition to its proteolytic functions (Caulfield and Lathem, 2012; Caulfield 
et al., 2014; Perry and Fetherston, 1997; Sodeinde et al., 1988). 
Deletion of any of these factors from the Y. pestis genome attenuates lung 
lesion development and ultimately virulence of Y. pestis. Both the pgm- and pCD1- 
strains of Y. pestis are attenuated to such a degree that they can be studied under 
BSL 2 conditions instead of the BSL 3 conditions required for fully virulent Y. pestis. 
While there have been many studies on these virulence factors, there is still more 
information to be assembled using disease-relevant cell types and in vivo infection 
models. 
 
3.3 Methods 
All reagents were obtained form Sigma-Aldrich™ unless otherwise noted. 
 
3.3.1 Ethics statement 
The use of live vertebrate animals was performed in accordance with the 
Public Health Service (PHS) policy on Humane Care and Use of Laboratory Animals, 
the Amended Animal Welfare Act of 1985, and the regulations of the United States 
Department of Agriculture (USDA). All animal studies were approved by the 
University of North Carolina at Chapel Hill Office of Animal Care and Use, protocols 
#12-028.0 and #15-022.0. 
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3.3.2 Bacterial strains and culture conditions 
The fully virulent Yersinia pestis strain CO92 and the plasmid-cured strain 
(pCD1-) were obtained from the U.S. Army, Ft. Detrick, MD. The presence or 
absence of pCD1 and the pgm locus was confirmed by PCR for each strain before 
use. The construction of Y. pestis strains Δpla and ΔyopH has previously been 
described (Lathem et al., 2007; Price et al., 2012). Yop deletion strains (ΔyopE, J, 
M, O, T) were constructed using a lambda red recombination system as described 
previously (Price et al., 2012). The yopM gene was complemented back into its 
native site on the pCD1 plasmid using the pSR47S recombination method as 
previously described (Cathelyn et al., 2006; Walker and Miller, 2004). 
Strains were grown on brain-heart infusion (BHI) agar (Difco Laboratories) at 
26°C for two days. For infections, liquid cultures of Y. pestis CO92 were grown in 
BHI broth for 6–12 h at 26°C. The cultures were then diluted to an OD620 of 0.05–0.1 
in BHI supplemented with 2.5 mM CaCl2 and grown 12–16h at 37°C with constant 
shaking.  
 
3.3.3 Animals and infections 
Six- to eight-week old female C57BL/6J mice were obtained from Jackson 
Laboratories. Mice were provided with food and water ad libitum and maintained at 
25°C and 15% humidity with alternating 12 h periods of light and dark. For animal 
infections, groups of three to ten mice were lightly anesthetized with 
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ketamine/xylazine and inoculated intranasally with a lethal dose of 104
 
colony-
forming units (CFUs) suspended in 20μL PBS. Actual CFUs inoculated was 
determined by plating serial dilutions of the inoculum on BHI. Moribund animals were 
euthanized with an overdose of sodium pentobarbital. For determination of bacterial 
burden, lungs were removed at the indicated times and homogenized in PBS using a 
Dremel® Tissue Homogenizer. Serial dilutions of each organ homogenate were 
plated on BHI agar and reported as CFU/lung. 
 
3.3.4 Isolation of primary human neutrophils and in vitro assays 
Human blood samples were obtained anonymously from consenting donors 
through the UNC Center for AIDS Research Virology Core Laboratory by common 
venipuncture according to IRB protocols #96-0859 and #08-0328. Blood was mixed 
with equal parts of a 3% dextran in 0.9% saline solution at room temperature for 
erythrocyte sedimentation. The top serum layer was removed and centrifuged at 250 
x g at 4°C for 10 min and the supernatant was removed. The pellet was 
resuspended in 0.9% saline and underlaid with Ficoll-Paque™ PLUS (GE 
Healthcare®). The gradient was centrifuged at 400 x g at 26°C for 40 min and both 
gradient layers were removed. To remove the remaining erythrocytes the pellet was 
resuspended in 0.2% saline for 1 min. An equal volume of 1.6% saline was added 
and the suspension was centrifuged at 250 x g at 4°C for 6 min. This erythrocyte 
wash was repeated and the final pellet was resuspended in cold PBS. Neutrophils 
were enumerated using a hemocytometer.  
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 For in vitro assays 12-well cell culture plates (Costar®) were pre-incubated 
with fetal bovine serum for 1 h at 37°C. FBS was removed and the wells were 
washed three times with PBS. Wells were plated with ~106 freshly isolated 
neutrophils suspended in modified RPMI media (RPMI 1640 without phenol red and 
HEPES and with L-glutamine (Gibco™) was buffered to pH 7.2 with 0.25 mM 
HEPES) and each well was supplemented with 5% FBS (HyClone™), 2.0 mM L-
glutamine (CellGro™), and 2.5 mM CaCl2. The cells were then inoculated with 
various strains of Y. pestis or treated with chemical inhibitors for 24 h at 37°C with 
5% CO2. The chemical inhibitors BI-D1870 (Cayman Chemical Co.™) and Z-YVAD-
FKM (BioVision™) were used at various concentrations to inhibit the kinase activity 
of RSK isoforms and inhibit the active site of caspase-1, respectively. 
 
3.3.5 Harvesting and staining of neutrophils for flow cytometry 
 Neutrophils were resuspended in wells by repetitive pipetting, collected into 
Eppendorf tubes, and spun 2 min at 1000 x g. Cells were washed in 2% FBS in PBS 
(flow buffer) and pelleted by spinning 2 min at 1000 x g. Cells were resuspended in 
antibody staining solution (flow buffer plus desired conjugated antibodies at a 1:200 
concentration: CD11b-phyoerythrin (Clone M1/70.15; Invitrogen), Ly6G-
phycoerythrin-Cy7 (Clone 1A8; BD Bioscience) on ice for 30 min. Cells were then 
stained for the apoptotic marker phosphatidylserine using Annexin V-FITC and for 
cell death using Propidium Iodide (Annexin V Apoptosis Detection kit FITC, 
Affymetrix™) as per the manufacturers instructions. A Guava easyCyte™ 5HT flow 
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cytometer (EMD Millipore™) was used to detect cell staining in a 96-well plate 
format. Flow cytometry results were analyzed using InCyte Software (EMD 
Millipore™), analyzed in Microsoft Excel™ and graphs were generated using 
GraphPad Prism™. 
 
3.3.6 Histopathology and TUNEL staining 
Groups of three mice were inoculated intranasally as described above, and 
lungs were inflated with 10% neutral buffered formalin via tracheal cannulation, then 
removed and incubated in 10% formalin for a minimum of 24 h. Lungs were 
immersed in 70% EtOH, and embedded in paraffin. Five-μm lung sections were 
adhered to glass slides, stained with hematoxylin/eosin for examination, and a 
coverslip was added. 
A TUNEL Apo-Green Detection kit (Biotool™) was used to detect damaged 
DNA indicative of apoptosis. Stained slides were mounted with SlowFade® Gold 
with DAPI (Invitrogen™) and coverslips were added prior to imaging with an 
Olympus BX60 fluorescence microscope and iVision software v. 4.0.0 (BioVision 
Technologies). All images were imported into Adobe Photoshop® to merge color 
channels. Input levels were then uniformly adjusted for images from the same 
staining experiment for publication purposes.   
 
3.4 Results 
Based on pathway analysis of the LCM/RNAseq data in Chapter 2 I wanted to 
verify that Y. pestis alters neutrophil death pathways leading to increased survival, 
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which may contribute to continued lesion expansion. 
 
3.4.1 Yersinia pestis effects on human neutrophil survival in vitro. 
I compared the survival of uninoculated primary human neutrophils to both Y. 
pestis- and non-pathogenic Escherichia coli-inoculated neutrophils in vitro. At 24 
hours post infection (hpi) neutrophils were harvested for analysis of apoptotic and 
dying cells by flow cytometry. An aliquot of cells was also fixed at 0 hpi to retain the 
initial starting concentration of neutrophils in each assay. After 24 hpi, the population 
of remaining “healthy” (AnnexinV-, PI-) neutrophils ranged from 40-60% of the initial 
seeding population depending on the donor. Inoculation with non-pathogenic E. coli 
resulted in survival of only 20-30% of the initial population. In contrast, inoculation 
with Y. pestis resulted in 60-80% survival of the initial population (Figure 3.1A), a 
significant increase in surviving healthy neutrophils compared to uninoculated or E. 
coli-inoculated neutrophils. 
 
3.4.2 Role of the type III secretion system in increased survival of human 
neutrophils  
After determining that Y. pestis significantly increased the survival of 
neutrophils, I tested if this could be attributed to a known virulence determinant of Y. 
pestis. I inoculated human neutrophils in vitro with Y. pestis strains lacking the 
pigmentation locus (pgm-), the plasminogen activator protease (Δpla), and the 
plasmid encoding the T3SS (pCD1-). I observed that neutrophils inoculated with a 
	   69	  
pgm- or Δpla mutant showed similar survival to those inoculated with wild type Y. 
pestis, while infection with a pCD1- mutant significantly decreased neutrophil survival 
(data not shown and Figure 3.1B), indicating that the phenotype is dependent on the 
T3SS. I next tested mutants of the six primary T3SS effectors (ΔyopE, ΔyopH, 
ΔyopJ, ΔyopM, ΔyopO, ΔyopT) in the neutrophil assay and observed that only 
infection with the ΔyopM mutant showed a significant decrease in neutrophil survival 
compared to inoculation with wild type Y. pestis (Figure 3.1C). I also observed that a 
ΔyopM:yopM complemented strain reproduced the phenotype of the wild type strain 
(Figure 3.1D), and validated my conclusion that YopM is important in modulating 
neutrophil survival. 
 
3.4.3 A novel function for YopM in neutrophil survival  
YopM is known to have two intracellular functions: (i) binding ribosomal S6 
kinase (RSK) and protein kinase N1 (PKN) (McDonald et al., 2003), which induces 
prolonged activation of RSK (Hentschke et al., 2010); and (ii) inhibiting caspase-1 
activity and inflammasome formation that leads to pyroptotic cell death (Chung et al., 
2014; LaRock and Cookson, 2012). To determine which function of YopM might be 
responsible for enhancing neutrophil survival, I performed a neutrophil infection 
assay in the presence of inhibitors of these two functions. To test the effect of 
continued YopM-induced RSK activity on neutrophil survival, I used the RSK inhibitor 
BI-D1870. Addition of increasing doses of BI-D1870 to neutrophils inoculated with 
wild type Y. pestis showed no decrease in neutrophil survival (Figure 3.2A), 
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indicating that the prolonged kinase activity of RSK induced by YopM had no effect 
on neutrophil survival. I validated the functionality BI-D1870 by monitoring the 
phosphorylation of the S6 protein (Roux et al., 2007) at the highest tested dose of 
this RSK inhibitor. Even after 24 hours, neutrophils treated with BI-D1870 showed 
decreased phosphorylation of S6 (Figure 3.3). I next tested the effect of inhibiting 
caspase-1 during inoculation with a ΔyopM mutant, using the caspase-1 inhibitor Z-
YVAD-FMK. In the presence of this inhibitor, neutrophil survival was not enhanced 
after inoculation with the ΔyopM mutant compared to uninoculated neutrophils. I did 
observe an overall increase in neutrophil survival in samples treated with Z-YVAD-
FMK, though this was significantly lower than the survival seen during infection with 
wild type Y. pestis. This indicates that there is a certain amount of caspase-1-
dependent neutrophil death, but this is not the mechanism through which YopM is 
acting (Figure 3.2B). These findings suggest a novel function of YopM specifically 
related to neutrophil survival that does not involve its known functions of RSK and 
PKN binding or caspase-1 inhibition. 
 
3.4.4 Role of YopM in the inhibition of apoptosis in lung lesions  
Since YopM is important for prolonging neutrophil survival in vitro, I tested if 
YopM is involved in sustaining neutrophil health within inflammatory lung lesions in 
vivo. Lungs of mice infected with wild type or ΔyopM Y. pestis were collected at 48 
hpi and sectioned for hematoxylin & eosin staining. Neither the size nor number of 
inflammatory lesions was significantly altered in the ΔyopM-infected lungs compared 
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to wild type infection. The bacterial burden in the lungs was similar between the two 
infections, but there was a significant decrease in the bacterial burden in spleens of 
ΔyopM-infected mice (Figure 3.3A). This decreased spleen burden indicates a 
decreased ability of Y. pestis to disseminate from the lungs. While the overall pattern 
of pulmonary inflammation was similar between the two infections (Figure 3.3B,C), 
the centers of the largest inflammatory foci in the ΔyopM mutant displayed more 
prominent necrosis of the alveolar septa. I also observed a striking difference in lung 
lesion cellular appearance between wild type and ΔyopM mutant-infected mice 
(Figure 3.3D, E). In the ΔyopM mutant-infected tissues, increased numbers of 
neutrophils were degranulated and had faded nuclei. Additionally, amidst viable 
inflammatory cells there were individual amphophilic cell bodies (3-5 µm in diameter, 
round to slightly misshapen) that lacked a discernible nucleus and often displayed 
faint stippling (Figure 3.3E blue arrows). Correspondingly, I observed increased DNA 
damage via fluorescent TUNEL staining in lung lesions of ΔyopM mutant-infected 
mice compared to wild type Y. pestis-infected mice (Figure 3.4). This TUNEL 
staining is indicative of apoptotic cell death and correlates with the presence of the 
amphophilic cell bodies. These in vivo observations confirm the importance of YopM-
induced neutrophil survival in vitro.  Furthermore, these results are consistent with 
the RNAseq analysis suggesting that the cells in the center of lesions have a 
decreased capacity to undergo apoptosis during wild type Y. pestis infection, leading 
to the distinctive lung lesions seen in pneumonic plague.  
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3.5 Discussion 
In this chapter I sought to confirm that apoptosis is inhibited during Y. pestis 
infection in vitro and in vivo, and also identify the bacterial factor(s) that are 
responsible for this phenotype. I therefore inoculated primary human neutrophils with 
fully virulent Y. pestis, as well as a repertoire of mutant strains lacking key virulence-
related genes for a more detailed analysis. Prior to inoculation, Y. pestis was grown 
at 37°C and was not pre-opsonized to most closely mimic conditions during 
pneumonic plague disease (Lathem et al., 2005). It has previously been observed 
that the pCD1 virulence plasmid of Y. pestis is necessary to inhibit neutrophil 
production of reactive oxygen species and decrease neutrophil apoptosis (Spinner et 
al., 2010). Though I initially began evaluating apoptosis and death of neutrophils I 
found that, despite an obvious loss of viable neutrophils, AnnexinV staining was not 
consistently different by 24 hpi. While neutrophils express phosphatidylserine as a 
marker of apoptosis, they continue to progress through apoptosis and are no longer 
detectable by flow cytometry at later time points. Thus, examining a singular time 
point only visualizes cells that are currently apoptotic and fails to capture those that 
have already gone through apoptosis. I therefore changed my readout to detect 
surviving “healthy neutrophils” by subtracting the apoptotic neutrophils (AnnexinV+), 
dead neutrophils (PI+), and neutrophils that became undetectable by flow cytometry 
due to turnover (subtracting neutrophils at 24 hpi from total starting neutrophils) from 
the starting number of neutrophils. I have shown with this assay that Y. pestis leads 
to increased survival of primary human neutrophils, and that the T3SS effector YopM 
is necessary for this phenotype. This is the first direct evidence that a single Y. 
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pestis gene is able to extend the survival of neutrophils.  
After testing for the known YopM functions of RSK activation and caspase-1 
inhibition, I was unable to confirm that either of these functions had any effect on 
neutrophil survival in vitro. I hypothesize that, similar to YopJ/P (Spinner et al., 
2010), YopM has a function in neutrophils that differs from what is observed in 
macrophages. YopM was initially shown to bind α-thrombin (Leung et al., 1990) and 
subsequently α1-antitrypsin (Heusipp et al., 2006), though neither of these binding 
functions contribute to Y. pestis virulence (Leung et al., 1990). YopM was later 
shown to bind p90 ribosomal S6 kinase (RSK) and protein kinase N1 (PKN) isoforms 
(McDonald et al., 2003). The C-terminal end of YopM binds phosphorylated RSK 
(McCoy et al., 2010), inhibiting dephosphorylation and prolonging its kinase activity 
(Hentschke et al., 2010). YopM binding to RSK and PKN also facilitates activated 
RSK to phosphorylate PKN and activate its kinase activity (McDonald et al., 2003). 
The RSK and PKN binding domains of YopM are required for IL-10 production 
during a Y. pseudotuberculosis intravenous infection (McPhee et al., 2010) and the 
deletion of these domains result in attenuation of virulence (McPhee et al., 2012). 
More recently it has been shown that YopM can also bind both active caspase-1 
(LaRock and Cookson, 2012) and IQGAP1 (Chung et al., 2014), depending on the 
isoform of YopM being tested. Both of these binding activities lead to an inhibition of 
inflammasome assembly and impede pyroptosis in macrophages. Other studies 
have shown the effects of YopM on bubonic plague and systemic infection through 
cytokine analysis and organ-specific cell composition of lesions (Kerschen et al., 
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2004; Ye et al., 2014; 2009; 2011), but this is the first study to suggest a function of 
YopM during pneumonic plague as well as its ability to  promote neutrophil survival. 
The influence of YopM on apoptosis of neutrophils has been previously 
studied in systemic infection by a pgm- strain of Y. pestis, and appears to be organ-
specific (Ye et al., 2014). My work focuses on neutrophils and pathology in the lung 
during infection with a fully virulent Y. pestis strain. I demonstrate the importance of 
YopM for neutrophil survival in vitro as well as for neutrophil integrity and reduction 
of apoptosis in vivo, as demonstrated by lesion histopathology and TUNEL staining. 
Linking the in vitro phenotype of increased neutrophil survival to apoptosis in vivo 
further validates the LCM-RNAseq conclusion that the apoptosis pathway is inhibited 
in the center of lung lesions compared to the periphery. The decrease in 
disseminated bacteria is intriguing, as it implies that YopM prevents Y. pestis killing 
by neutrophils. The function of neutrophils is typically to attack invading bacteria, 
degranulate, and undergo apoptosis, necrosis, or the formation of neutrophil 
extracellular traps (NETs). Along with observing cells that lacked a discernable 
nucleus, we detected increased, diffuse TUNEL staining after infection with the 
ΔyopM mutant strain. This physiology and diffuse damaged DNA staining could 
suggest the formation of neutrophil extracellular traps (NETs) within the lung lesions. 
Further investigating the formation of NETs after infection with a ΔyopM mutant 
strain of Y. pestis could elucidate the specific function that YopM is having on 
neutrophils. However, the continuing hypothesis for the line of questioning leading 
into Chapter 4 is that the increase in neutrophil survival may result from the failure to 
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degranulate, suggesting that YopM is inhibiting degranulation of neutrophils and 
buildup of granule contents is aiding in lung lesion formation. 
In summary, I introduced a unique application of LCM technology to examine 
directly the spatially distinct microenvironments resulting from host-pathogen 
interactions during primary pneumonic plague. As a result, I was able to show that Y. 
pestis modulates neutrophil survival in vivo in a YopM-dependent manner. Further 
defining and characterizing mediators of the dramatic pulmonary inflammation that 
occurs during pneumonic plague will help in understanding the lethality of this 
disease and may contribute to our understanding of severe pulmonary infection with 
other respiratory pathogens.  
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3.6 Figures 
 
Figure 3.1: The type III secretion system effector YopM is necessary for 
enhanced neutrophil survival 
Primary human neutrophils were incubated in buffered RPMI at 37°C and 5% CO2, 
with or without bacterial inoculation. After 24 hours, remaining “healthy neutrophils” 
were assayed by flow cytometry (CD16+, CD66b+, AnnexinV-, 7-AAD/PI-). (A) After 
incubation with wild type Y. pestis, there were significantly more healthy neutrophils 
compared to both uninoculated cells and non-pathogenic E. coli-inoculated cells. (B) 
After incubation with a Δpla mutant, there was no difference in healthy neutrophils 
compared to inoculation with wild type Y. pestis. However, inoculation with a pCD1- 
(T3SS negative) mutant caused a significant decrease in healthy neutrophils. (C) 
Comparing inoculations with six individual T3SS effector mutants, only the ΔyopM 
mutant significantly decreased the percentage of healthy neutrophils compared to 
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inoculation with wild type Y. pestis. (D) Complementation of the ΔyopM strain 
restored neutrophil survival to the level seen with wild type Y. pestis. Results are 
from representative experiments performed in triplicate. Data are represented as 
mean ± SEM; asterisks represent statistical significance based on Tukey’s multiple 
comparison tests from an ordinary one-way ANOVA, **p < 0.01, ***p < 0.001. 
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Figure 3.2: Inhibiting known functions of YopM does not alter neutrophil 
survival  
Primary human neutrophils were incubated with or without bacterial inoculation and 
drug treatment. After 24 hours, remaining “healthy neutrophils” were assayed by flow 
cytometry (CD16+, CD66b+, AnnexinV-, 7-AAD/PI-). (A) Treatment with the RSK 
inhibitor BI-D1870 had no effect on the percentage of healthy neutrophils in culture 
for either uninoculated or wild type Y. pestis-inoculated samples. (B) Treatment with 
the caspase-1 inhibitor Z-YVAD-FMK showed a significant increase in the 
percentage of healthy neutrophils compared to untreated samples.  However, there 
was also still a significant difference in the percentage of healthy neutrophils 
remaining in uninoculated and ΔyopM mutant-inoculated samples compared to wild 
type Y. pestis-inoculated samples. Results are from representative experiments 
performed in triplicate. Data are represented as mean ± SEM; asterisks represent 
statistical significance based on Tukey’s multiple comparison tests from an ordinary 
one-way ANOVA, ***p < 0.001.  
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Figure 3.3: BI-D1870 continues to inhibit RSK activity after 24 hours in isolated 
human neutrophils 
Primary human neutrophils were incubated with or without bacterial inoculation and 
RSK inhibitor (BI-D1870). After 24 hours, neutrophils were harvested and lysed for 
Western blot analysis. Treatment with the BI-D1870 caused a decrease in the 
phosphorylation of S6 in both uninoculated and wild type Y. pestis-inoculated 
samples, even after 24 hours.  
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Figure 3.4: YopM-dependent effects on bacterial burden and histopathology 
during pulmonary infection with Y. pestis 
(A) At 48 hpi, there is no difference in lung bacterial burden but there is a significant 
difference in spleen bacterial burden between mice infected with wild type and 
ΔyopM mutant Y. pestis. (B, C) At low magnification there is no distinct difference in 
size or number of lung lesions in mice infected with wild type or ΔyopM mutant Y. 
pestis. (D, E) At higher magnification, however, large numbers of necrotic cells can 
be seen throughout the lung lesions in mice infected with the ΔyopM mutant 
(representative cells marked with blue arrows) that are not present during an 
infection with wild type Y. pestis. Scale bar in images represents (B, C) 200 μm or 
(D, E) 20 μm. Data are compiled from two separate experiments and represented as 
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geometric mean ± 95% CI; asterisks represent statistical significance based on 
Mann-Whitney tests, **p < 0.005. 
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Figure 3.5: TUNEL staining of infected mouse lung sections 
Representative composite images of lung lesions (48 hpi) stained for damaged DNA 
using TUNEL (green) and total DNA using DAPI (blue). TUNEL staining, generally 
indicative of apoptosis, was primarily restricted to lung lesions during Y. pestis 
infection.  More apoptosis was evident in the lung lesions of mice infected with the 
ΔyopM mutant compared to those infected with wild type Y. pestis.  
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CHAPTER 4: CHARACTERIZING THE IMPACT OF REACTIVE 
OXYGEN/NITROGEN SPECIES IN VIVO DURING PNEUMONIC PLAGUE 
 
4.1 Overview 
This chapter describes the in vivo characterization of small reactive molecule 
stresses that Y. pestis experiences within the lung during pneumonic plague. 
Activated neutrophils release both reactive oxygen and nitrogen species (ROS and 
RNS) that can kill bacteria, but may also injure host cells. I initially hypothesized that 
the inflammatory lung lesions that develop during pneumonic plague are a result of 
host-mediated injury via ROS and RNS. In the work described in this chapter, 
however, I provide evidence to the contrary that indicates ROS and RNS play a 
significant role in hindering early establishment of Y. pestis during pneumonic 
plague. Both the extent of lung injury and bacterial burdens in the lungs were 
increased when these stresses were negated in a murine intranasal infection. This 
work is the first to evaluate in vivo how these small host defense molecules affect 
the tissue damage and lesion composition in lungs during pneumonic plague. 
Characterizing innate immune stresses, and how Y. pestis is affected by them, will 
lead to a better understanding of Y. pestis - host interactions during pneumonic 
plague, and may help to identify new therapeutics that can prolong the treatment 
window for Y. pestis infection. 
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4.2 Introduction 
The studies presented in this chapter focus on the small molecules, termed 
reactive oxygen species (ROS) and reactive nitrogen species (RNS), that are 
generated by neutrophils and other innate immune cells in response to infection. 
These small molecules act during host defense to kill invading microbes by 
disrupting normal cell function, but can also incidentally injure the host. Therefore, a 
delicate balance must be kept to prevent extensive host damage while maintaining 
the antimicrobial activity of ROS/RNS. Consequently, many bacteria have evolved 
mechanisms to counteract oxidative and nitrosative bursts. If an immune response is 
prolonged due to bacterial resistance, ROS and RNS can cause damage to host 
tissue, particularly in a location like the alveolar spaces, which are lined by a single 
layer of epithelial cells (Folkerts et al., 2001). Based on the rapid neutrophil response 
and hyper-inflammatory state in the lungs late during pneumonic plague, the lung 
lesions that form may be the result of the over-production of ROS and RNS due to 
the uncontrolled burden of Y. pestis that replicates unchecked in the lungs early 
during infection (Lathem et al., 2005).  
In response to infection, most antimicrobial ROS are generated from the initial 
reaction of O2 and NADPH with the NADPH oxidase complex. This reaction 
generates superoxide (O2-) that can be converted to hydrogen peroxide (H2O2) and 
then to hydroxyl radicals. O2- can also react with nitric oxide (NO) to generate 
peroxynitrite (ONOO-), another potent reactive molecule (Bogdan et al., 2000; Fang, 
1997; Segal, 2005; Thomas et al., 1988). Additionally, conversion of H2O2 by 
neutrophil myeloperoxidase (MPO) can generate antimicrobial hypochlorous acid 
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(HOCl) and chloramines (Bogdan et al., 2000; Thomas et al., 1988). It is important 
for immune cells to control and target the ROS they produce due to their generalized 
pleiotropic and harmful effects. Proteins, lipids, DNA, and RNA can all be targets of 
oxygen radicals, and if ROS are overproduced they can damage the host through 
their interactions with these cellular components. Both the sugar moieties and the 
base structures of DNA and RNA can be targeted, resulting in strand breaks. 
Membrane lipids are attacked at polyunsaturated fatty acids to disrupt membrane 
fluidity and membrane-protein structures. Proteins can likewise be targeted, causing 
the modification of sulfur bonds, oxidation of amino acids around metal binding sites, 
and peptide fragmentation, among other effects (Cabiscol et al., 2000). 
Most RNS generated in response to bacterial infection result from the 
metabolism of L-arginine by the inducible nitric oxide synthase (iNOS) protein, which 
utilizes O2 and NADPH to form citrulline and NO. NO can be further converted into 
other antimicrobial RNS including ONOO-, S-nitrosothiols (RSNO), various nitrogen 
oxides, and dinitrosyl-iron complexes (Fang, 1997). NO can be an inflammatory 
mediator, up-regulating the production of over 20 cytokines within numerous cell 
types. Both NO and RSNOs can also affect the apoptotic potential of cells (Bogdan 
et al., 2000). Specifically within neutrophils, NO is important for recruitment and 
adhesion through cytokine regulation and integrin expression. RNS can work by 
altering transcription through signaling pathways, or can directly affect activity 
through tyrosine nitration of proteins (Bogdan, 2001). These RNS can hinder 
bacterial growth in many ways. For example, RSNOs can be generated through NO 
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reacting with SH-groups on free amino acids, which are able to disrupt metal-sulfur 
clusters to kill bacteria (Bogdan et al., 2000; Fang, 1997; Marcinkiewicz, 1997; 
Pacelli et al., 1995). Interestingly, there is some evidence that host-NO can react 
with bacterial-derived O2- and generate ONOO- within a bacterium to cause tyrosine 
nitration of bacterial proteins to affect their functions (Bogdan, 2001).  
The NADPH oxidase complex and iNOS have been studied in the context of 
many bacterial infections. Both ROS (Brennan et al., 2004; Cha et al., 2010; Jann et 
al., 2009; Mendez-Samperio et al., 2009; Pacelli et al., 1995) and RNS (Bogdan, 
2001; Brennan et al., 2004; Fang, 1997; Marcinkiewicz, 1997; Pacelli et al., 1995; 
Richardson et al., 2006) have been shown to be important to varying degrees in 
controlling a number of bacterial infections. In vitro studies of Y. pestis have 
described a role for these reactive small molecules in regulating bacterial gene 
expression and how the bacterium attempts to control host generation of these 
molecules (Paauw et al., 2009; Pradel et al., 2014; Sebbane et al., 2006). It is 
necessary, however, to define the role of ROS and RNS in vivo during pneumonic 
plague. If these mechanisms contribute to the progression of pneumonic plague, 
they could be manipulated to prolong the timeframe during which treatment is 
effective. The work described in this chapter examines the affects of both ROS and 
RNS on pneumonic plague using intranasal infection with a fully virulent strain of Y. 
pestis. The use of mouse strains that lack production of leukocyte based ROS 
(gp91phox-/-) and RNS (iNOS-/-) allow us to determine how these reactive species 
influence pneumonic plague disease progression and lesion development.  
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4.3 Methods 
All reagents were obtained form Sigma-Aldrich™ unless otherwise noted. 
 
4.3.1 Ethics statement 
The use of live vertebrate animals was performed in accordance with the 
Public Health Service (PHS) policy on Humane Care and Use of Laboratory Animals, 
the Amended Animal Welfare Act of 1985, and the regulations of the United States 
Department of Agriculture (USDA). All animal studies were approved by the 
University of North Carolina at Chapel Hill Office of Animal Care and Use, protocols 
#12-028.0 and #15-022.0. 
 
4.3.2 Bacterial strains and culture conditions 
The fully virulent Yersinia pestis strain CO92 was obtained from the U.S. 
Army, Ft. Detrick, MD. Y. pestis was grown on brain-heart infusion (BHI) agar (Difco 
Laboratories) at 26°C for two days. For infections, liquid cultures of Y. pestis CO92 
were grown in BHI broth for 6–12 h at 26°C. The cultures were then diluted to an 
OD620 of 0.05–0.1 in BHI supplemented with 2.5 mM CaCl2 and grown 12–16h at 
37°C with constant shaking.  
 
4.3.3 Animals and infections 
Six- to eight-week old female C57BL/6J mice were obtained from Jackson 
Laboratories. Knockout mouse strains, gp91phox-/- and iNOS-/-, were originally 
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obtained from Jackson Laboratories and bred at the University of North Carolina at 
Chapel Hill according to the Division of Laboratory Animal Medicine regulations. 
Mice were provided with food and water ad libitum and maintained at 25°C and 15% 
humidity with alternating 12 h periods of light and dark. For animal infections, groups 
of three to ten mice were lightly anesthetized with ketamine/xylazine and inoculated 
intranasally with a lethal dose of 103-104
 
colony-forming units (CFUs) suspended in 
20μL PBS. Actual CFUs inoculated was determined by plating serial dilutions of the 
inoculum on BHI. Mice were continuously monitored at 12-hour intervals and scored 
for disease severity. If mice were moribund at any time point they were humanely 
euthanized as per the Animal Care and Use protocol. 
 
4.3.4 Bacterial organ burden determination 
After humanely euthanizing infected mice, both lungs and spleens are removed and 
separately placed into conical tubes containing PBS. Organs were homogenized in 
the PBS using a Dremel® tissue homogenizer. Dilutions of tissue homogenate were 
prepared samples were spotted onto BHI agar. Agar was incubated at 26°C for 2 
days to allow for growth of the bacterial colony forming units (CFUs). The CFUs 
were enumerated and back-calculating the dilutions revealed the bacterial burden 
per organ.  
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4.3.5 Lung histopathology staining 
Groups of three mice were inoculated intranasally as described above. At the 
defined time point mice were humanely euthanized and lungs were inflated with 10% 
neutral buffered formalin via tracheal cannulation, then removed and incubated in 
10% formalin for a minimum of 2 h. Lungs were placed in phosphate buffered saline 
(pH 7.4) with 30% Sucrose and 20% O.C.T. compound (Tissue-Tek®) for 3 h with 
intermittent inverting. Lungs were removed, covered in O.C.T. for 10 min, frozen on 
dry ice, and stored at -80°C. Ten-μm lung sections were adhered to glass slides, 
stained with hematoxylin/eosin for examination, and a coverslip was added. 
 
4.4 Results 
 Chapters 2 and 3 of this Dissertation have shown that during pneumonic 
plague, neutrophils aggregate outward from small initiating foci and suffer from a 
lack of turnover and cell clearance, which results in alveolar destruction late during 
pneumonic plague. This damage likely results from neutrophil defense mechanisms 
such as degranulation and the release of granule contents as new neutrophils begin 
infiltrating into the lungs. These neutrophil granules include proteins and protein 
complexes that generate ROS and RNS that can lead to damaging effects on host 
tissue. Determining the effects of ROS and RNS on lung lesion development will give 
insight into how components of the innate immune response cause alveolar damage 
during pneumonic plague. 
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4.4.1 Histological comparison of the effects of reactive oxygen and nitrogen 
species on pneumonic plague lung lesions 
 To determine the effects of small ROS and RNS molecules on the 
development of lung lesions during pneumonic plague, I obtained gp91phox-/- mice 
lacking the ability to produce ROS from the leukocyte NADPH oxidase complex, and 
iNOS-/- mice lacking the ability to produce RNS. Mice were infected via intranasal 
inoculation with 104 fully virulent Y. pestis, and lungs were harvested at various time 
points and sectioned for gross histopathological analysis by hematoxylin and eosin 
staining. At 36 hpi, C57BL/6J (wild type) mice showed very little lung damage with 
only a few small foci beginning to form (Figure 4.1A). Alternatively, infected iNOS-/- 
and gp91phox-/- mice both had significant lung lesion development by 36 hpi. Lungs 
of iNOS-/- mice displayed levels of inflammatory damage similar to what is seen in 
the lungs of wild type mice later at 48 hpi (Figure 4.1C, 4.1B respectively). Similarly, 
lungs of gp91phox-/- mice had more consolidated lesions by 36 hpi, and also 
appeared similar to wild type lungs at 48 hpi (Figure 4.1E, 4.1B respectively). This 
difference was less defined at later time points during infection, where by 48 hpi the 
lungs of iNOS-/- mice had a similar amount of lung area covered by lesions as wild 
type mice. However, the distribution of lesions appeared unique: there tended to be 
fewer but larger lesions that likely cause more severe alveolar damage at this later 
time point in the lungs of iNOS-/- mice (Figures 4.1D).  In contrast, lung lesion 
development in gp91phox-/- mice displayed more coverage of lung surface area, and 
lungs contained visibly more lesions compared to wild type mice (Figure 4.1F).  
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4.4.2 Determining the effects of ROS/RNS on bacterial burden after intranasal 
infection with Y. pestis 
 The more advanced lesion development in the lungs of both iNOS-/- and 
gp91phox-/- mice at 36 hpi led me to question whether there were differences in 
bacterial burden within the organs of these mice. To this end, both lung and spleen 
burdens were assessed at 36 and 48 hpi in all three strains of mice after intranasal 
inoculation with 104 Y. pestis CFUs. Spleen burden is a representative assessment 
of bacterial dissemination from the lungs (Lathem et al., 2005). The Y. pestis burden 
in the lungs of all three strains of mice remained equivalent at both 36 and 48 hpi 
(Figure 4.2). Bacterial burden in the spleen, however, was altered between the three 
mouse strains. While at 36 hpi there was no significant difference in spleen burdens 
between the three strains of mice, there was a clear trend that the iNOS-/- and 
gp91phox-/- mice had higher spleen burdens at this time point (Figure 4.2). The 
difference in spleen bacterial burden became more apparent by 48 hpi, where both 
the iNOS-/- and gp91phox-/- mice had significantly higher bacterial burdens compared 
to those seen in wild type mice (Figure 4.2). These findings imply that dissemination 
is occurring earlier in the iNOS-/- and gp91phox-/- mice, suggesting that 
establishment of Y. pestis in the lungs is unhindered in these mice compared to wild 
type mice.  
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4.4.3 Survival of mice lacking the ability to produce small reactive species 
Based on differences in both lung lesion area and Y. pestis burdens in the 
spleen, I sought to determine if the absence of ROS and RNS effected the survival of 
mice during pneumonic plague. An intranasal dose of 103 Y. pestis was administered 
to wild type, iNOS-/-, and gp91phox-/- mice. Due to the extremely rapid progression of 
pneumonic plague this lower dose was used to attempt to compensate for the 
overwhelming burden normally experienced in wild type mice. I could then better 
determine survival differences specifically do to earlier development of disease. The 
health of all mice was assessed every 12 hours, and when the mice became 
moribund they were euthanized and the span of their survival was recorded. While 
iNOS-/- mice had a moderately extended time to death compared to wild type mice, 
this difference was not statistically significantly. Likewise, gp91phox-/- mice had a 
similar survival time as wild type mice (Figure 4.3). This data suggests that, while 
small reactive molecules may have effects on lung lesion development and 
composition, they are dispensable in relation to survival during our mouse model of 
infection. 
 
4.5 Discussion 
While several laboratories have demonstrated relevance of innate immune 
cells (including neutrophils) during plague infection (Grabenstein et al., 2006; 
Kerschen et al., 2004; Laws et al., 2010; Lukaszewski et al., 2005; Marketon et al., 
2005; O'Loughlin et al., 2010; Pechous et al., 2013; Pujol and Bliska, 2005; Welkos 
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et al., 1998; Zauberman et al., 2006), there is a lack of information regarding 
whether neutrophils use small reactive species such at ROS and RNS to control Y. 
pestis within lung lesions during pneumonic plague. Neutrophils are able to confer 
several different stresses on bacteria while attempting to control infection 
(Kobayashi et al., 2003; Segal, 2005; Tsai and Grayson, 2008). We predicted that 
ROS/RNS likely contribute to lung damage in pneumonic plague due to the densely 
packed, neutrophil-rich nature of the inflammatory lung lesions (Bogdan, 2001; 
Bogdan et al., 2000; Brennan et al., 2004; Fang, 1997; Pacelli et al., 1995; Roos et 
al., 2003; Segal, 2005). While ROS (Gao et al., 2011; Sebbane et al., 2006), RNS 
(Sebbane et al., 2006), and neutrophils (Laws et al., 2010; O'Loughlin et al., 2010) 
have each proven effective in combating Y. pestis in vitro, no comprehensive study 
has observed these effects during pneumonic plague, a disease characterized 
largely as the destruction of lung tissue by a hyper-activated innate immune 
response (Lathem et al., 2005).  
In this chapter, I sought to determine the in vivo affects of small reactive 
molecules on disease progression and development of lung lesions during 
pneumonic plague. To perform these studies I utilized two strains of knockout mice: 
iNOS-/- and gp91phox-/-. In generating ROS, neutrophils utilize a specific 
phagocytic/leukocyte version of NADPH oxidase that contains the gp91phox (NOX2) 
subunit (Brandes and Kreuzer, 2005). The specificity of this gp91phox subunit can 
be taken advantage of, and gp91phox-/- mice can be used to study the depletion of 
leukocyte ROS (Gao et al., 2002). Inhibiting the NADPH oxidase complex in this 
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manner can also affect the generation of ROS by MPO since H2O2, a downstream 
product generated by the NADPH oxidase complex, is necessary for the activity of 
MPO (Bogdan et al., 2000). In generating RNS, there are three forms of NOS: 
inducible, endothelial, and neuronal. The eNOS protein is necessary for vasodilation, 
nNOS is necessary for neuronal cell communication, and both aid in the regulation of 
blood pressure (Folkerts et al., 2001; Forstermann and Sessa, 2012). The iNOS 
protein is found expressed in cells as a defense response to invading pathogens, 
and is therefore primarily found in innate immune cells or cells such as airway 
epithelial cells that act as sentinels to detect and combat invading pathogens 
(Bogdan et al., 2000; Folkerts et al., 2001). The specificity of iNOS during infection 
can be taken advantage of, and iNOS-/- mice can be used to study the depletion of 
RNS in vivo (MacMicking et al., 1995; Wei et al., 1995). 
The observation that small lung lesions begin to develop at 36 h after 
intranasal infection of wild type mice with Y. pestis is consistent with previous 
findings in the Goldman lab (Lathem et al., 2005). It was therefore surprising to 
observe that larger lesions had developed by 36 h in the lungs of both the iNOS-/-, 
and gp91phox-/- mice after intranasal infection. This was contrary to my initial 
hypothesis that ROS and RNS were responsible for a large amount of damage in the 
lungs after infection, and that their depletion would mitigate much of this damage. On 
the contrary, this data suggests that both ROS and RNS play a role in preventing 
initial establishment of Y. pestis in the lungs. 
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Along with early lesion development, the increased dissemination of Y. pestis 
from the lungs of both iNOS-/- and gp91phox-/- mice may indicate that there is an 
initial stalling of Y. pestis by these reactive species that prevents earlier systemic 
spread. There is a potential correlation between the increase in bacterial 
dissemination, as determined by bacterial burden in the spleen, and the earlier 
development of larger lung lesions. An increase in the spleen burden of both the 
iNOS-/- and gp91phox-/- mice suggests that dissemination from the lungs begins 
earlier during these infections. This earlier infiltration could lead to lesions 
developing earlier in the iNOS-/- and gp91phox-/- mice after intranasal infection with 
Y. pestis. This could imply that there is a threshold of bacterial burden or host 
damage in the lungs that triggers dissemination, and without these reactive species 
Y. pestis is less adept at disseminating from the lungs into distal tissues.  
The initial hypothesis that ROS and RNS were responsible for extensive 
damage within lung lesions also predicted that there would be an increase in the 
survival of the iNOS-/- and gp91phox-/- mice once that damage was mitigated. Upon 
observing that there was earlier lesion development and increased dissemination in 
knockout mice, it was not surprising that there was no change in iNOS-/- or 
gp91phox-/- mouse survival compared to wild type mice after intranasal challenge. 
On the contrary, my current model suggests that the iNOS-/- and gp91phox-/- mice 
would succumb to disease more quickly due to the advanced progression of lesion 
formation and increased septicemia. It is possible that using an inoculum above the 
LD50 for Y. pestis overwhelms the mouse and masks any significant change in 
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survival. Use of a lower inoculum, at which not all wild type mice succumb to 
infection, may be necessary to observe a change in survival in the iNOS-/- and 
gp91phox-/- mice. 
A great deal of work has focused specifically on Y. pestis itself, or the direct 
interaction of bacteria with specific host innate immune cells. However, as Y. pestis 
represents a potential bio-weapon threat, more research should focus on a whole-
host view of disease. Observing in vivo immune responses during disease 
progression allows for the identification of new pathways that could not be identified 
with in vitro assays alone. Y. pestis vaccine research is primarily focused on proteins 
known to directly interact with host cells. In addition to these, Y. pestis proteins 
affecting and responding to the environment may be equally important. This unique 
look at the effect of ROS and RNS in lung lesions gives insight into how individual 
molecules can affect disease symptoms. It also offers a peek into the potential 
information that may be revealed when the RNAseq data from Chapter 2 are 
evaluated to identify patterns in genes affected by the generation of ROS and RNS.  
 
  
	   101	  
4.6 Figures 
 
Figure 4.1: Comparative histopathology of wild type, iNOS-/-, and gp91phox-/- 
mice during intranasal Y. pestis infection 
At 36 hpi lung sections of (A) wild type mice infected with 104 Y. pestis had very little 
apparent inflammation. At this same time point, lungs sections of both (C) iNOS-/- 
and (E) gp19phox-/- mice had much more progressed inflammation with the 
development of sizeable lesions. At 48 hpi (B) lung sections of wild type showed the 
typical progressive development of lung lesions. At this same time point lung 
sections of (D) iNOS-/- mice had a few expansive lung lesions taking up a majority of 
individual lung lobes. Lung sections of (F) gp91phox-/- mice had an abundant number 
of lesions throughout all lobes of the lung consuming a large expanse of the lung. All 
representative images are captured at 40x magnification. 
 
A! B!
C! D!
E! F!
36 hpi! 48 hpi!
wild type!
iNOS-/-!
gp91phox-/-!
	   102	  
 
Figure 4.2: Bacterial burden of both the lung and spleen of wild type, iNOS-/-, 
and gp91phox-/- mice during intranasal Y. pestis infection 
After intranasal infection with 104 Y. pestis, wild type, iNOS-/-, and gp91phox-/- mice 
were euthanized at various time points to obtain a measurement of bacterial burden. 
(A) After 36 hpi the lung burden of all 3 mouse strains were equivalent. Spleen 
burden also did not show a significant change, but there was a trend of higher 
burden in iNOS-/- and gp91phox-/- mice. (B) After 48 hpi the lung burden of all 3 
mouse strains was still equivalent. Spleen burden differences had become more 
apparent and there was a significant increase in burden for both iNOS-/- and 
gp91phox-/- mice compared to wild type mice. Data are from representative 
experiments and represented as geometric mean ± 95% CI; asterisks represent 
statistical significance based on Mann-Whitney tests, *p < 0.05. 
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Figure 4.3: Survival graph of wild type, iNOS-/-, and gp91phox-/- mice during 
intranasal Y. pestis infection 
All mice were inoculated with 103 Y. pestis and were observed for disease 
symptoms. Wild type, iNOS-/-, and gp91phox-/- had median survival times of 72 h, 84 
h, and 72 h respectively. Data is represented as percent survival of mice and there 
was no significant difference in survival by log-rank Mantel-Cox tests. 
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CHAPTER 5: DISCUSSION AND FUTURE EXPERIMENTS 
 
5.1 Summary of results 
Chapter 1 of this dissertation gives a brief overview of the intriguing past of 
Yersinia pestis and how plague disease has altered human history. It also focuses 
on pneumonic plague and discusses the lung and the innate immune system that 
attempts to control infection but instead leads to lung damage and pneumonia.  
While in vitro work is certainly critical to advancing our understanding of 
pathogenesis, certain information can only be obtained through in vivo analysis 
during infection. Chapter 2 tackles this in vivo research using a novel method to 
evaluate infection in the lung, using LCM and RNAseq to investigate spatial 
differences in transcription within inflammatory sites after intranasal inoculation with 
fully virulent Y. pestis. We isolated RNA from the center and periphery of the 
inflammatory lung lesions that form during the later stages of pneumonic plague in 
order to define, by generating a transcriptome using RNAseq, how Y. pestis was 
affecting the cells present in these two regions. In addition, we isolated and 
sequenced RNA from bone marrow isolated neutrophils (BM-PMNs) of infected and 
uninfected mice as a distal match to our lung samples, providing us with a gene 
repertoire that was known to be neutrophil-specific. By performing statistical 
comparisons between the lesion center and periphery, and separately between the 
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uninfected and infected BM-PMNs, we uncovered 976 and 3,198 genes that were 
significantly different between these comparisons, respectively. Comparing these 
two gene sets resulted in a list of 224 genes with an enrichment value of p=0.02 that 
represented genes in the lung lesion comparison that were neutrophil specific. The 
transcriptional profiles for the 224 genes were then clustered to identify patterns 
between the four tested groups based on the differential regulation between the two 
comparisons (e.g. A gene is up-regulated in the infected BM-PMNs compared to the 
uninfected BM-PMNs and then down-regulated in the lesion center compared to the 
lesion periphery). Interestingly, we observed that the profiles of the uninfected BM-
PMN and lesion center regulation clustered together, while the infected BM-PMN 
and lesion periphery regulation profiles clustered together, indicating that neutrophil 
transcription profiles in the center of the lesions are more similar to “unstimulated” 
neutrophils (The above example would represent this profile phenotype). This 
apparent down-regulation of neutrophil transcription was supported through density 
curve analysis of defined gene sets using a ratio of genes in the lesion periphery 
compared to the lesion center. We found that gene sets involved in leukocyte 
(neutrophil) migration and apoptotic pathways were overall more down-regulated in 
the center of lung lesions compared to the periphery, indicating that these pathway 
functions were being down-regulated in the center of lesions. For example, more 
genes in the apoptosis pathways were being down regulated than expected by 
chance, indicating that neutrophils in the center of lesions are hindered in going 
through apoptosis. 
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Chapter 3 validates the RNAseq analysis that indicated genes involved in 
neutrophil apoptosis are down-regulated in the lesion centers. In vitro infection 
assays using isolated human neutrophils were subsequently employed to evaluate 
the survival of neutrophils after challenge with various bacterial strains. We 
concluded that, compared to neutrophils that were uninfected or infected with non-
pathogenic Escherichia coli, fully virulent Y. pestis infection caused an increase in 
neutrophil survival after 24 h. We went on to identify the T3SS effector YopM as 
being important in causing this prolonged survival of neutrophils. Despite identifying 
a role for YopM, the mechanism of YopM function in this system remains unknown. 
We tested the two known intracellular binding functions of YopM using the 
appropriate inhibitors, but preventing either of the known functions had no effect on 
neutrophil survival. Moving to our in vivo mouse model of infection, we determined 
that YopM is important for the composition of lung lesions during pneumonic plague. 
We observed a significant population of cells, presumably neutrophils, which appear 
to be degranulated in the lungs of mice infected with a ΔyopM strain of Y. pestis. 
This observation also correlates with increase TUNEL staining within lung lesions 
after a ΔyopM infection, indicative of increased apoptosis. This supports the in vitro 
data and indicates that Y. pestis prolongs neutrophil survival in vivo in a YopM-
dependent manner. 
Chapter 4 focuses on the role of reactive small molecules released by 
neutrophils that should kill invading bacteria, but can end up harming host tissue in 
the process. Interestingly, these in vivo studies involving intranasal infection of wild 
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type, iNOS-/-, and gp91phox-/- mouse strains with Y. pestis, indicated that both ROS 
and RNS may be important for hindering early establishment of Y. pestis in the 
lungs. The lung histopathology of both the iNOS-/-, and gp91phox-/- mice showed 
increased lung damage compared to wild type mice after infection. Both iNOS-/-, and 
gp91phox-/- mice also had increased dissemination of bacteria from their lungs as 
observed by bacterial burden in spleens. These differences did not significantly 
affect the survival of infected iNOS-/-, and gp91phox-/- mice at the doses tested. 
Together, these three chapters unite to better define the cause of lung lesion 
development during pneumonic plague by looking directly at interactions of Y. pestis 
with relevant cell types in an in vivo intranasal infection model. 
 
5.2 Filling gaps in plague research 
Several laboratories have demonstrated the relevance of innate immune cells 
during plague pathogenesis (Laws et al., 2010; Marketon et al., 2005; Pechous et 
al., 2013), and the effects on macrophages (Grabenstein et al., 2006; Pujol and 
Bliska, 2005; Zauberman et al., 2006) and neutrophils (O'Loughlin et al., 2010; 
Spinner et al., 2013; 2008; 2010; Welkos et al., 1998) after interacting with various 
virulence determinants of Y. pestis. Despite this work, there remains a large gap in 
the field regarding the inability of neutrophils, the most abundant cell type interacting 
with Y. pestis in the lungs during pneumonic plague (Pechous et al., 2013), to control 
Y. pestis infection leading to the lesions seen in this disease. Prior to the research 
presented in this dissertation, no in-depth analysis has been performed to determine 
how Y. pestis may be altering neutrophil function within the lungs to facilitate lesion 
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expansion in the absence of noticeable immune cell or bacterial clearance. Isolating 
the most relevant cell type in lung lesions and using assay conditions that most 
closely mimic the extracellular nature of Y. pestis during pneumonic plague (Price, 
2011) enhanced the study of this common theme throughout this dissertation. A 
unique tissue level approach is described in Chapter 2 that investigated the effects 
of Y. pestis on neutrophils in vivo. Evaluation of the spatial differences in gene 
regulation within lung lesions not only allows for the isolation for relevant cell types, 
but also highlights the idea that there are some questions that cannot be tackled 
using in vitro assays and attenuated Y. pestis strains. Through the use of LCM and 
RNAseq, we specifically evaluated neutrophil transcript regulation within lung lesions 
that developed during pneumonic plague. In Chapter 2, we evaluated three sets of 
genes for their spatial regulation within lesions, and found that two of these sets 
were significantly altered between the two regions. The RNAseq approach offers the 
opportunity to look for host pathways that are differentially regulated within these 
sites of tissue damage to identify how neutrophils are altered after interaction with Y. 
petsis. Additionally, chapter 3 addresses the issue of Y. pestis altering neutrophil 
function during pneumonic plague, and identifies that the T3SS effector protein 
YopM alters neutrophil survival both in vitro and in vivo.  
Chapter 3 also investigates the unique nature of lung lesions that continue to 
expand throughout disease. We are the first group to focus on the composition of 
these lesions and how they establish within the lung. Very few of the neutrophils 
within these lesions appear to be undergoing apoptosis despite the highly 
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inflammatory microenvironment and significant bacterial numbers in the lungs. The 
characterization of a role for YopM in Chapter 3 begins to elucidate these 
observations, and shows how the unique composition of these lung lesions is partly 
dependent on the ability of YopM to inhibit the progression of neutrophils through the 
apoptotic pathway. The reason why there is not a more drastic reduction in lesion 
size during infection with a ΔyopM Y. pestis mutant is likely due to the pleiotropic 
effects of other Yops, which will be investigated in detail in future studies.  
It is unknown what aspects of the immune response are responsible for the 
alveolar damage that occurs during pneumonic plague. It is possible that the lack of 
neutrophil turnover is a primary cause of alveolar destruction. As a result of this lack 
of turnover more activated neutrophils infiltrate and aggregate to form the lesions. 
These infiltrating neutrophils may be causing a heightened level of damage through 
releasing ROS and RNS while attempting to control the infection and continuously 
calling more neutrophils to the site of infection. While some research suggests that 
neutrophils can kill Y. pestis in vitro (Laws et al., 2010; O'Loughlin et al., 2010), 
these bacteria are able to persist in infected lungs despite massive neutrophilic 
influx. Current research has not addressed this in vitro/in vivo difference or defined 
the immune stresses present in the lung lesion microenvironment that may be the 
cause of host damage. Chapter 4 begins to reveal the impact of neutrophil defense 
mechanisms, and whether their granule contents contribute to lung lesion 
development and damage. This chapter suggests that ROS and RNS contribute to 
the control of Y. pestis in the lung, but not enough to contain infection, which soon 
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runs rampant in the lungs and disseminates to other organs in the body. Further 
investigations of the neutrophil granule contents will help to address which of these 
components can be manipulated to aid in treating pneumonic plague. 
Many studies focus specifically on individual Y. pestis virulence factors and 
how they alone interact with host immune cells. Y. pestis vaccine research is also 
based mainly on specific Y. pestis surface proteins known to directly interact with 
host cells. However, the work presented in this dissertation has taken a different 
approach by focusing on how the host and Y. pestis respond in the context of an 
actual infection and not as individual components of cells or bacteria. This research 
is innovative in how it accounts for the host - Y. pestis interactions leading to lung 
lesion formation and identifies genes that are altered within the lesion 
microenvironments. No other group has looked specifically at lung lesions to 
determine how Y. pestis is able to survive and persist within this hyper-inflammatory 
host microenvironment. Continued research in these unexplored areas of Y. pestis 
infection may not only affect pneumonic plague treatment, but may also reveal 
factors involved in acute lung infection with other pathogens. 
  
5.3 Implications for the study of plague and pathogen-associated tissue 
damage 
 Much of the research in the Y. pestis field is performed in vitro and with 
attenuated strains of the bacterium. In the past, these approaches have been 
important for studying individual virulence factors and their functions, but lack in the 
ability to wholly translate to fully virulent disease. While the necessity of a BSL 3 
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laboratory has slowed research on this historically important pathogen, The 
Goldman lab has consistently used fully virulent Y. pestis, and virulence factor 
mutants, to gain a greater appreciation for virulence in vivo (Lathem et al., 2007; 
2005; Pechous et al., 2013; 2015; Price et al., 2012; Sivaraman et al., 2015) and the 
work in this dissertation continues in this vein. This more biologically relevant model 
allows us to ask questions that could not be tackled using in vitro assays or 
attenuated Y. pestis strains.  
Combining the use of fully virulent organisms with the applications of LCM 
and RNAseq has allowed us to dissect regions of lung lesions that form during the 
late stage of pneumonic plague disease. Isolating RNA from separate regions of the 
center and periphery of these lesions allowed assessment of unique 
microenvironments within the lungs. The ultimate goal of this work was to observe 
how Y. pestis interactions with the host affected the transcription of infiltrating 
neutrophils, eventually causing the development of histopathologically distinct lung 
lesions. This technique, however, may have much broader appeal to the bacterial 
pathogenesis community. I have hypothesized, and observed, that even between 
relatively small regions of damaged tissue, there are observable spatial differences 
in how host cells are responding. This approach could be used in similar systems 
where pathogen-induced host damage leads to severe disease complications or 
death of the host. Investigating host pathways that could be manipulated to alter the 
mechanisms by which damage is occurring may bring about approaches for 
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specifically targeting the immune system to allow for more efficient treatment of 
infections.  
 For in vitro assays, we also used relevant cell types and assay conditions for 
the questions we were asking. This has become more important recently, as it has 
been observed that at least one of the Yop effector proteins has different effects on 
different cell types (Spinner et al., 2010). We have recently shown that neutrophils 
seem to be selectively targeted for injection by the Y. pestis T3SS and are the cell 
type most important for lung lesion development (Pechous et al., 2013). We 
therefore wanted to use neutrophils in the in vitro assays presented in this 
dissertation. Our findings that YopM has a novel undefined function in prolonging 
neutrophil survival only emphasizes the importance of using relevant cells types 
during research. Neutrophils are a notoriously difficult cell type to assay, but we 
emphasize with this work that, while immortalized and derived cell lines can be 
extremely useful, primary cells of the relevant lineages are necessary to more deeply 
understand the pathogenesis of diseases. Likewise, we ensure that we are using the 
most relevant assay conditions for our study. While several labs pre-grow Y. pestis 
at room temperature and pre-opsonize the bacteria prior to functional infection 
assays, we utilized conditions most relevant to pneumonic plague. We mimic primary 
pneumonic plague by pre-growing Y. pestis at 37°C to mimic the lung temperature 
prior to person-to-person transmission, and we do not pre-opsonize our bacteria 
since we observe very little intracellular Y. pestis during pneumonic plague. Varying 
conditions in other neutrophil studies could very well explain some of the conflicting 
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data on their ability to kill Y. pestis and how they are affected by various virulence 
factors (Laws et al., 2010; Lukaszewski et al., 2005; O'Loughlin et al., 2010; Spinner 
et al., 2010). Better defining the interactions between the host and Y. pestis that are 
responsible for the formation of lung lesions and pneumonia will lead to a better 
understanding of Y. pestis infection and identification of potential treatments to 
improve survival during a Y. pestis infection. 
In conclusion, my work has advanced the field by introducing a new method 
for analyzing the transcription of cells within areas of tissue damage caused by 
bacterial infection. I have also characterized the effects of both bacterial and host 
factors on the lung lesions that develop during pneumonic plague, including the Y. 
pestis T3SS effector YopM and host ROS and RNS.  
 
5.4 Future Experiments 
 Future work on the studies performed within this dissertation will continue to 
lead to a better understanding of Y. pestis disease development. This new 
information can be utilized to prolong the time window during which treatment can be 
effectively delivered against pneumonic plague and other inflammatory respiratory 
pathogens. Below are suggestions for continuing the work in this dissertation to 
define the lung damage caused by the interaction of Y. pestis and neutrophils: 
 
1. Continue generating gene lists of interest and testing them on the 
density curve model to find pathways that are altered between the 
lesion periphery and center.  
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2. Perform LCM to isolate Y. pestis RNA from the periphery and center 
of lesions to transcript profiles after RNAseq. 
3. Perform qRT-PCR on lung lesion-obtained RNA for genes in the 
pathways identified as being altered in the density curve model to 
identify genes which are truly regulated by the interactions of Y. 
pestis. 
4. Perform qRT-PCR analyses on lung lesion-obtained RNA from mice 
infected with ΔyopM and wild type Y. pestis to compare apoptosis 
pathway genes and determine how YopM is inhibiting cell turnover 
and increasing the survival of neutrophils. 
5. Explore how the degranulation of neutrophils alters infection and the 
survival of Y. pestis.  Particularly investigate a ΔyopM mutant and 
the effect YopM may have on neutrophil degranulation based on 
histology of lungs from ΔyopM-infected mice. 
6. Investigate the formation of NETs by neutrophils after infection with 
a ΔyopM mutant based on histology of lungs from ΔyopM-infected 
mice. Also explore the effect of NET formation on Y. pestis survival. 
7. Test a ΔlcrV Y. pestis mutant (The component of the T3SS that 
encodes the tip of the needle necessary for injecting the effectors) or 
double-Δyop mutants, in the neutrophil assay. This will help 
determine if the ΔyopM mutant-infected neutrophil phenotype (in 
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between wild type and pCD1- infections) is due to compensation 
from other Yops or is due to some other factor on the pCD1 plasmid. 
8. Generate lists of host genes that are regulated by the presence of 
ROS and RNS and plot them on a density curve model using the 
RNAseq data to identify regulation of these genes in lung lesions. 
9. Infect iNOS-/- and gp91phox-/- mice with ΔyopM Y. pestis to observe 
how the lack of ROS or RNS response affects lesion formation when 
neutrophils are more readily going through apoptosis (and 
presumably degranulating). 
10. Monitor survival of wild type, iNOS-/-, and gp91phox-/- mice at the Y. 
pestis LD50 of wild type mice to determine of the more advanced 
lung lesions in iNOS-/- and gp91phox-/- mice cause increased 
mortality. 
11. Test strains of knockout mice which are deficient for components of 
neutrophils granules such as myeloperoxidase, neutrophil elastase, 
or various proteases (Eyles et al., 2006; Faurschou and Borregaard, 
2003) to determine components of neutrophil defense important for 
lesion formation. 
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